[DEFM14A] Streamline Health Solutions, Inc. Merger Proxy Statement

Q: What is the cash price offered to STRM shareholders in the merger?

Each share of STRM will receive $5.34 in cash , without interest, upon closing.

Q: How big is the premium over Streamline Health’s pre-announcement share price?

The offer represents a 138% premium to the 28 May 2025 close and 117% over the 30-day VWAP.

Q: When is the shareholder vote for STRM’s merger with MDaudit?

The virtual Special Meeting is scheduled for 9:00 a.m. ET on 7 August 2025 .

Q: What vote is needed to approve the merger proposal?

At least 66 ⅔ % of all outstanding STRM shares must vote FOR; non-votes count as AGAINST.

Q: Are appraisal rights available to dissenting STRM shareholders?

Yes. Holders who strictly follow DGCL §262 can seek a court-determined “fair value” instead of the $5.34 cash.

Q: Is the deal subject to financing or regulatory approvals?

The buyer has sufficient cash on hand ; no financing condition exists, and only customary legal clearances are required.

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

DEFM14A

Rhea-AI Filing Summary

Streamline Health Solutions, Inc. (Nasdaq: STRM) has mailed a Definitive Proxy Statement (DEFM14A) asking shareholders to approve its all-cash acquisition by Mist Holding Co./MDaudit for $5.34 per share. The Special Meeting will be held virtually on 7 August 2025. If completed, Merger Sub will merge into Streamline, turning the company into a wholly-owned subsidiary of MDaudit, after which STRM shares will be delisted and deregistered.

Financial terms: Holders receive $5.34 in cash for each share—representing a 138% premium to the 28 May 2025 close and a 117% premium to the 30-day VWAP. All restricted shares and in-the-money options/warrants convert to cash on the same economic basis; out-of-the-money options and warrants are cancelled for no consideration. The buyer has certified it possesses sufficient cash, and the deal is not subject to a financing condition.

Approvals & key hurdles: • Merger Proposal requires an unusually high two-thirds (66 ⅔ %) of outstanding STRM shares. • Compensation and Adjournment Proposals require a simple majority of votes cast. • 21.82% of shares are already locked up via Voting Agreements with officers/directors. • Outside closing date is 31 Dec 2025; parties target 3Q-2025 completion. • Standard closing conditions apply, including no injunctions and accuracy of reps & warranties.

Governance & deal protections: • Streamline has a customary “no-shop” clause with fiduciary-out and five-business-day match right. • A termination fee of $950,000 (≈2.3% of equity value) is payable under specified circumstances, including a superior proposal. • Appraisal rights are available to shareholders who strictly follow DGCL §262 procedures.

Strategic rationale highlighted by the Board: Cain Brothers opined that the consideration is fair from a financial perspective. Directors cite immediate liquidity at a substantial premium, certainty of value, and lack of financing risk. The Board unanimously recommends voting “FOR” all three proposals.

Implications for investors: Shareholders gain immediate cash at a triple-digit premium but forgo future upside and lose public equity liquidity. Failure to achieve the two-thirds threshold or satisfy closing conditions would leave STRM independent, potentially causing the share price to revert toward pre-announcement levels. Active voting is critical because non-votes count as “AGAINST” the Merger Proposal.

Streamline Health Solutions, Inc. (Nasdaq: STRM) ha inviato un Definitive Proxy Statement (DEFM14A) chiedendo agli azionisti di approvare la sua acquisizione in contanti da parte di Mist Holding Co./MDaudit a $5,34 per azione. L'Assemblea Straordinaria si terrà virtualmente il 7 agosto 2025. Se completata, Merger Sub si fonderà in Streamline, trasformando la società in una controllata interamente di proprietà di MDaudit, dopodiché le azioni STRM saranno ritirate dalla quotazione e cancellate dalla registrazione.

Termini finanziari: I detentori riceveranno $5,34 in contanti per ogni azione, pari a un premio del 138% rispetto al prezzo di chiusura del 28 maggio 2025 e del 117% rispetto alla media ponderata dei volumi (VWAP) a 30 giorni. Tutte le azioni vincolate e le opzioni/warrant in the money saranno convertiti in contanti sulla stessa base economica; le opzioni e warrant out of the money saranno annullati senza alcun compenso. L'acquirente ha certificato di possedere liquidità sufficiente e l'accordo non è soggetto a condizioni di finanziamento.

Approvazioni e ostacoli chiave: • La proposta di fusione richiede una maggioranza qualificata di due terzi (66 ⅔ %) delle azioni STRM in circolazione. • Le proposte di compensazione e rinvio richiedono la maggioranza semplice dei voti espressi. • Il 21,82% delle azioni è già vincolato da accordi di voto con dirigenti e amministratori. • La data limite per la chiusura è il 31 dicembre 2025; le parti puntano a completare entro il terzo trimestre 2025. • Si applicano le condizioni standard di chiusura, inclusa l'assenza di ingiunzioni e la correttezza delle dichiarazioni e garanzie.

Governance e protezioni dell’accordo: • Streamline ha una clausola “no-shop” consueta con eccezione fiduciaria e diritto di pari offerta entro cinque giorni lavorativi. • È prevista una penale di risoluzione di $950.000 (circa il 2,3% del valore azionario) in casi specifici, inclusa la presentazione di un’offerta superiore. • Gli azionisti possono esercitare il diritto di valutazione seguendo rigorosamente le procedure della DGCL §262.

Ragioni strategiche evidenziate dal Consiglio: Cain Brothers ha giudicato giusta la considerazione da un punto di vista finanziario. I direttori sottolineano liquidità immediata a un premio sostanziale, certezza del valore e assenza di rischio di finanziamento. Il Consiglio raccomanda all’unanimità di votare “A FAVORE” di tutte e tre le proposte.

Implicazioni per gli investitori: Gli azionisti ottengono liquidità immediata con un premio a tre cifre, ma rinunciano a potenziali guadagni futuri e perdono la liquidità del mercato pubblico. Il mancato raggiungimento della soglia dei due terzi o il mancato soddisfacimento delle condizioni di chiusura lascerebbe STRM indipendente, con possibile ritorno del prezzo delle azioni ai livelli pre-annuncio. È fondamentale votare attivamente, poiché i voti non espressi sono considerati "CONTRARI" alla proposta di fusione.

Streamline Health Solutions, Inc. (Nasdaq: STRM) ha enviado un Definitive Proxy Statement (DEFM14A) solicitando a los accionistas aprobar su adquisición total en efectivo por parte de Mist Holding Co./MDaudit a $5.34 por acción. La Junta Especial se realizará de manera virtual el 7 de agosto de 2025. Si se completa, Merger Sub se fusionará con Streamline, convirtiendo a la empresa en una subsidiaria propiedad total de MDaudit, tras lo cual las acciones de STRM serán retiradas de la cotización y desregistradas.

Términos financieros: Los titulares recibirán $5.34 en efectivo por cada acción, lo que representa una prima del 138% sobre el cierre del 28 de mayo de 2025 y una prima del 117% sobre el VWAP de 30 días. Todas las acciones restringidas y las opciones/warrants in the money se convertirán en efectivo con la misma base económica; las opciones y warrants out of the money se cancelan sin compensación. El comprador ha certificado que posee suficiente efectivo y el acuerdo no está sujeto a una condición de financiamiento.

Aprobaciones y obstáculos clave: • La propuesta de fusión requiere una mayoría calificada inusual de dos tercios (66 ⅔ %) de las acciones en circulación de STRM. • Las propuestas de compensación y aplazamiento requieren mayoría simple de votos emitidos. • El 21.82% de las acciones ya está bloqueado mediante acuerdos de voto con oficiales/directores. • La fecha límite para el cierre es el 31 de diciembre de 2025; las partes apuntan a completar en el tercer trimestre de 2025. • Se aplican condiciones estándar de cierre, incluyendo ausencia de órdenes judiciales y precisión de declaraciones y garantías.

Gobernanza y protecciones del acuerdo: • Streamline tiene una cláusula habitual de “no-shop” con excepción fiduciaria y derecho de igualación de cinco días hábiles. • Se paga una tarifa de terminación de $950,000 (≈2.3% del valor patrimonial) en circunstancias específicas, incluida una propuesta superior. • Los accionistas tienen derechos de tasación si siguen estrictamente los procedimientos del DGCL §262.

Razonamiento estratégico destacado por la Junta: Cain Brothers opinó que la contraprestación es justa desde una perspectiva financiera. Los directores citan liquidez inmediata con una prima sustancial, certeza de valor y ausencia de riesgo de financiamiento. La Junta recomienda unánimemente votar “A FAVOR” de las tres propuestas.

Implicaciones para los inversores: Los accionistas obtienen efectivo inmediato con una prima de tres dígitos, pero renuncian a la posible apreciación futura y pierden la liquidez del mercado público. No alcanzar el umbral de dos tercios o no cumplir las condiciones de cierre dejaría a STRM independiente, lo que podría hacer que el precio de las acciones vuelva a niveles previos al anuncio. Es crucial votar activamente, ya que la falta de voto cuenta como "EN CONTRA" de la propuesta de fusión.

Streamline Health Solutions, Inc. (나스닥: STRM)는 Mist Holding Co./MDaudit에 의한 주당 5.34달러 현금 인수를 승인해 달라는 Definitive Proxy Statement (DEFM14A)를 주주들에게 발송했습니다. 특별 주주총회는 2025년 8월 7일 온라인으로 개최됩니다. 인수가 완료되면 Merger Sub가 Streamline과 합병되어 회사는 MDaudit의 완전 자회사로 전환되며, 이후 STRM 주식은 상장 폐지 및 등록 말소됩니다.

재무 조건: 주주들은 주당 5.34달러 현금을 받게 되며, 이는 2025년 5월 28일 종가 대비 138%, 30일 VWAP 대비 117% 프리미엄에 해당합니다. 제한 주식과 인더머니(in-the-money) 옵션/워런트는 동일한 경제적 기준으로 현금 전환되며, 아웃오브머니(out-of-the-money) 옵션과 워런트는 보상 없이 취소됩니다. 매수자는 충분한 현금을 보유하고 있음을 증명했으며, 거래는 자금 조달 조건에 구애받지 않습니다.

승인 및 주요 장애물: • 합병 제안은 발행 주식의 3분의 2 이상(66 ⅔ %)의 찬성이 필요합니다. • 보상 및 연기 제안은 투표수 과반수 찬성이 필요합니다. • 21.82%의 주식은 임원 및 이사들과의 투표 계약으로 이미 잠겨 있습니다. • 거래 종료 예정일은 2025년 12월 31일이며, 양측은 2025년 3분기 완료를 목표로 하고 있습니다. • 표준 종료 조건이 적용되며, 금지 명령 부재 및 진술과 보증의 정확성이 포함됩니다.

거버넌스 및 거래 보호: • Streamline은 통상적인 “노샵(no-shop)” 조항을 두고 있으며, 수탁자 예외 및 5영업일 내 맞대응권이 있습니다. • 특정 상황(우월 제안 포함)에서 95만 달러(약 2.3%의 지분 가치) 해지 수수료가 지급됩니다. • 주주는 DGCL §262 절차를 엄격히 준수할 경우 감정권을 행사할 수 있습니다.

이사회가 강조한 전략적 이유: Cain Brothers는 재무적 관점에서 대가가 공정하다고 평가했습니다. 이사들은 즉각적인 현금화와 상당한 프리미엄, 가치 확실성, 자금 조달 위험 부재를 언급했습니다. 이사회는 세 가지 제안 모두에 대해 만장일치로 “찬성” 투표를 권고합니다.

투자자에 대한 시사점: 주주들은 세 자릿수 프리미엄으로 즉시 현금을 얻지만, 미래 상승 가능성을 포기하고 공개 주식의 유동성을 잃게 됩니다. 3분의 2 찬성 요건을 충족하지 못하거나 종료 조건을 만족하지 못하면 STRM은 독립 상태를 유지하며, 주가가 발표 전 수준으로 돌아갈 수 있습니다. 비투표는 합병 제안에 대해 “반대”로 간주되므로 적극적인 투표 참여가 매우 중요합니다.

Streamline Health Solutions, Inc. (Nasdaq : STRM) a envoyé une déclaration de procuration définitive (DEFM14A) demandant aux actionnaires d’approuver son acquisition entièrement en numéraire par Mist Holding Co./MDaudit à 5,34 $ par action. L’assemblée extraordinaire se tiendra virtuellement le 7 août 2025. En cas de réalisation, Merger Sub fusionnera avec Streamline, transformant la société en filiale à 100 % de MDaudit, après quoi les actions STRM seront radiées et désenregistrées.

Conditions financières : Les détenteurs recevront 5,34 $ en espèces par action — représentant une prime de 138 % par rapport au cours de clôture du 28 mai 2025 et une prime de 117 % par rapport au VWAP sur 30 jours. Toutes les actions restreintes et les options/bonnes de souscription dans la monnaie seront converties en espèces sur la même base économique ; les options et bons hors de la monnaie seront annulés sans contrepartie. L’acheteur a certifié disposer de liquidités suffisantes, et l’accord n’est pas soumis à une condition de financement.

Approbations et obstacles clés : • La proposition de fusion requiert une majorité qualifiée inhabituelle des deux tiers (66 ⅔ %) des actions STRM en circulation. • Les propositions de rémunération et de report requièrent une majorité simple des votes exprimés. • 21,82 % des actions sont déjà verrouillées par des accords de vote avec les dirigeants/directeurs. • La date limite de clôture est le 31 décembre 2025 ; les parties visent une finalisation au troisième trimestre 2025. • Les conditions habituelles de clôture s’appliquent, incluant l’absence d’injonctions et l’exactitude des déclarations et garanties.

Gouvernance et protections de l’accord : • Streamline dispose d’une clause classique de « no-shop » avec une exception fiduciaire et un droit de premier refus de cinq jours ouvrables. • Des frais de résiliation de 950 000 $ (≈2,3 % de la valeur des capitaux propres) sont payables dans des circonstances spécifiques, y compris en cas d’offre supérieure. • Les droits d’évaluation sont disponibles pour les actionnaires respectant strictement les procédures DGCL §262.

Motivations stratégiques mises en avant par le Conseil : Cain Brothers a estimé que la contrepartie est équitable d’un point de vue financier. Les administrateurs soulignent la liquidité immédiate avec une prime substantielle, la certitude de la valeur et l’absence de risque de financement. Le Conseil recommande à l’unanimité de voter « POUR » les trois propositions.

Implications pour les investisseurs : Les actionnaires obtiennent un paiement immédiat en numéraire avec une prime à trois chiffres mais renoncent à une éventuelle plus-value future et perdent la liquidité des actions cotées. Le non-respect du seuil des deux tiers ou des conditions de clôture laisserait STRM indépendante, ce qui pourrait faire revenir le cours de l’action aux niveaux précédant l’annonce. Un vote actif est crucial car les abstentions sont comptées comme des votes « CONTRE » la proposition de fusion.

Streamline Health Solutions, Inc. (Nasdaq: STRM) hat eine endgültige Stimmrechtsvollmachtserklärung (DEFM14A) versendet, in der die Aktionäre gebeten werden, dem vollständigen Barerwerb durch Mist Holding Co./MDaudit zu 5,34 USD je Aktie zuzustimmen. Die außerordentliche Hauptversammlung wird virtuell am 7. August 2025 abgehalten. Wird der Abschluss vollzogen, fusioniert Merger Sub mit Streamline, wodurch das Unternehmen eine hundertprozentige Tochtergesellschaft von MDaudit wird. Anschließend werden die STRM-Aktien vom Handel ausgesetzt und gelöscht.

Finanzielle Bedingungen: Die Inhaber erhalten 5,34 USD in bar pro Aktie – was einer Prämie von 138 % gegenüber dem Schlusskurs vom 28. Mai 2025 und 117 % gegenüber dem 30-Tage-VWAP entspricht. Alle beschränkten Aktien sowie in-the-money Optionen/Warrants werden auf derselben wirtschaftlichen Basis in Bargeld umgewandelt; out-of-the-money Optionen und Warrants werden ohne Gegenleistung annulliert. Der Käufer hat bestätigt, über ausreichende liquide Mittel zu verfügen, und der Deal unterliegt keiner Finanzierungsbedingung.

Genehmigungen & wesentliche Hürden: • Der Fusionsvorschlag erfordert eine ungewöhnlich hohe Zweidrittelmehrheit (66 ⅔ %) der ausstehenden STRM-Aktien. • Vorschläge zu Vergütung und Vertagung erfordern einfache Mehrheit der abgegebenen Stimmen. • 21,82 % der Aktien sind bereits durch Stimmrechtsvereinbarungen mit Führungskräften/Directors gebunden. • Äußerstes Abschlussdatum ist der 31. Dezember 2025; Ziel ist ein Abschluss im dritten Quartal 2025. • Übliche Abschlussbedingungen gelten, einschließlich keiner einstweiligen Verfügungen und der Richtigkeit der Zusicherungen & Gewährleistungen.

Governance & Schutzmaßnahmen: • Streamline verfügt über eine übliche „No-Shop“-Klausel mit Treuhand-Ausnahme und einem fünf Werktage umfassenden Matching-Recht. • Eine Abbruchgebühr von 950.000 USD (≈2,3 % des Eigenkapitalwerts) ist unter bestimmten Umständen, einschließlich eines besseren Angebots, zu zahlen. • Bewertungsrechte stehen Aktionären zu, die die DGCL §262-Verfahren strikt einhalten.

Strategische Begründung laut Vorstand: Cain Brothers beurteilten die Gegenleistung aus finanzieller Sicht als fair. Die Direktoren verweisen auf sofortige Liquidität mit erheblicher Prämie, Wertsicherheit und kein Finanzierungsrisiko. Der Vorstand empfiehlt einstimmig, allen drei Vorschlägen „ZUZUSTIMMEN“.

Auswirkungen für Investoren: Aktionäre erhalten sofort Bargeld zu einem dreistelligen Aufschlag, verzichten jedoch auf zukünftiges Kurspotenzial und verlieren die Liquidität der öffentlichen Aktie. Wird die Zweidrittelmehrheit nicht erreicht oder die Abschlussbedingungen nicht erfüllt, bleibt STRM unabhängig, was zu einer Rückkehr des Aktienkurses auf das Vorankündigungsniveau führen könnte. Aktive Stimmabgabe ist entscheidend, da Nichtabstimmungen als „GEGEN“ den Fusionsvorschlag gewertet werden.

Positive

138% cash premium to the last unaffected trading price provides immediate, certain value to shareholders.
No financing condition; buyer has certified funds, reducing closing risk.
21.82% voting support already secured through director/officer lock-ups, improving deal visibility.
Low $950k termination fee keeps door open for superior proposals.
Cain Brothers fairness opinion supports Board’s view of financial adequacy.

Negative

Super-majority (66 ⅔ %) vote requirement means abstentions and non-votes count as AGAINST, elevating execution risk.
Shares will be delisted and deregistered, eliminating liquidity for any remaining minority holders.
Termination fee payable by Streamline if a superior proposal emerges and Board changes recommendation.
Appraisal process complexity could deter investors seeking a higher judicially-determined value.

Insights

TL;DR: Cash deal offers 138% premium, low break-fee, no financing risk; chief hurdle is 66 ⅔ % approval.

The $5.34 per-share consideration values Streamline at roughly 2.3× its pre-announcement market cap—high for a healthcare IT target of this size. With no financing contingency, funding risk is effectively removed. The 21.82% voting lock-up meaningfully de-risks the shareholder vote, yet the super-majority requirement leaves a narrow margin. The modest $0.95 m termination fee (≈$0.22/share) provides limited deterrence to rival bids, preserving optionality for shareholders. Overall, the structure is shareholder-friendly and likely to close unless an organized dissent emerges.

TL;DR: Attractive exit premium; loss of future upside and delisting risk for holdouts.

From a portfolio perspective, locking in a 138% instant gain in cash is compelling, especially for a micro-cap with historically volatile trading and thin liquidity. Post-deal, investors cannot participate in potential integration synergies, and appraisal proceedings may be lengthy and costly. Given the clear Board support, fairness opinion, and no financing caveats, probability-weighted expected value favors tendering support. Risk centers on failure to secure the two-thirds vote; monitor retail sentiment and proxy advisory recommendations closely.

07/10/2025 - 09:03 AM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐	Preliminary Proxy Statement

☐	Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☒	Definitive Proxy Statement

☐	Definitive Additional Materials

☐	Soliciting Material under §240.14a-12

Streamline Health Solutions, Inc.

(Name of Registrant as Specified In Its Charter)

N/A

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

☐	No fee required.

☒	Fee paid previously with preliminary materials.

☐	Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

Table of Contents

MERGER PROPOSED—YOUR VOTE IS VERY IMPORTANT

July 10, 2025

Dear Fellow Stockholder,

The Board of Directors (the “Streamline Board”) of Streamline Health Solutions, Inc., a Delaware corporation (“Streamline” or the “Company”) cordially invites you to attend a Special Meeting of Stockholders of the Company, to be held virtually on August 7, 2025, at 9:00 a.m. Eastern Time (including any adjournments or postponements thereof, the “Special Meeting”). The Special Meeting will be a completely virtual meeting of stockholders, conducted via live webcast. If you are a Streamline stockholder as of the close of business on June 23, 2025 (the “Record Date”), you will be able to attend and participate in the virtual Special Meeting, vote your shares electronically and submit your questions prior to and during the meeting by visiting https://meetnow.global/MJHXM7U at the meeting date and time described in the accompanying proxy statement. There is no physical location for the Special Meeting.

As previously announced, on May 29, 2025, we entered into an Agreement and Plan of Merger (as it may be amended from time to time, the “Merger Agreement”) with Mist Holding Co., a Delaware corporation and the parent company of Hayes Management Consulting LLC d/b/a MDaudit (“Parent” and, together with its affiliates, “MDaudit”), and MD BE Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”). Pursuant to the Merger Agreement, and upon the terms and subject to the conditions set forth therein, Merger Sub will be merged with and into Streamline, with Streamline continuing as the surviving corporation and becoming a wholly owned subsidiary of Parent (the “Merger”).

If the Merger is consummated, you will be entitled to receive $5.34 in cash, without interest, for each share of common stock, par value $0.01 per share, of Streamline (“Streamline common stock”) that you own as of immediately prior to the effective time of the Merger (the “Merger Consideration”) (other than any shares of Streamline common stock with respect to which you are entitled to demand, and have perfected a demand, for appraisal rights in accordance with Delaware law). The Merger Consideration represents a 138% premium to Streamline’s closing price on May 28, 2025, the last trading day prior to the public announcement of the Merger, and a 117% premium to Streamline’s 30-day volume weighted average stock price as of May 28, 2025.

The Streamline Board has unanimously (i) approved and declared advisable the Merger Agreement and the transactions contemplated by the Merger Agreement, including the Merger; (ii) determined that the Merger Agreement and the transactions contemplated by the Merger Agreement, including the Merger, are fair to, and in the best interests of, the Company and the holders of the shares of Streamline common stock; (iii) recommended that the holders of shares of Streamline common stock adopt the Merger Agreement at the Special Meeting; and (iv) directed that the Merger Agreement be submitted to the holders of shares of Streamline common stock for their adoption at the Special Meeting.

At the Special Meeting, you will be asked to consider and vote on a proposal to adopt the Merger Agreement (the “Merger Proposal”). At the Special Meeting, you also will be asked to consider and vote on (i) a proposal to approve, by non-binding advisory vote, certain compensation that may be paid or become payable to Streamline’s named executive officers in connection with the Merger (the “Compensation Proposal”), and (ii) a proposal to approve the adjournment of the Special Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes present or represented by proxy at the Special Meeting to approve the Merger Proposal (the “Adjournment Proposal”). The Merger Proposal requires the affirmative vote of at least two-thirds (66 2/3%) of the issued and outstanding shares of Streamline common stock entitled to vote thereon. Each of the Compensation Proposal and the Adjournment Proposal requires the affirmative vote of a majority of the shares of Streamline common stock present or represented by proxy at the Special Meeting and entitled to vote thereon.

The Streamline Board unanimously recommends that Streamline stockholders vote “FOR” the Merger Proposal, “FOR” the Compensation Proposal and “FOR” the Adjournment Proposal.

Table of Contents

Your vote is very important regardless of the number of shares of Streamline common stock that you own. Streamline and Parent cannot complete the Merger without the approval of the Merger Proposal by at least two-thirds (66 2/3%) of the issued and outstanding shares of Streamline common stock entitled to vote on the Merger Proposal. The failure of any Streamline stockholder to vote and any abstentions from voting on the Merger Proposal will have the same effect as a vote “AGAINST” the Merger Proposal.

The failure of any Streamline stockholder to vote will not have any effect on the Compensation Proposal or the Adjournment Proposal (assuming, in the case of the Compensation Proposal, a quorum is present). However, abstentions with respect to the Compensation Proposal and Adjournment Proposal will have the same effect as a vote “AGAINST” the Compensation Proposal and the Adjournment Proposal.

All proposals described in this proxy statement to be voted on at the Special Meeting are considered “non-routine” matters. Accordingly, if you are a beneficial owner and do not provide your bank, brokerage firm or other nominee instructions on how to vote your shares of Streamline common stock, your bank, brokerage firm or other nominee generally will not be permitted to vote your shares on any of the proposals. The effect of not instructing your broker how you wish your shares to be voted will be the same as a vote “AGAINST” the Merger Proposal, but will not have an effect on the Compensation Proposal or the Adjournment Proposal (assuming, in the case of the Compensation Proposal, a quorum is present).

Whether or not you plan to participate in the Special Meeting, Streamline urges you to submit a proxy in advance of the Special Meeting to have your shares voted by using one of the methods described in the accompanying proxy statement. If your shares are held in the name of a bank, brokerage firm or other nominee, please follow the instructions on the voting instruction card furnished by such bank, brokerage firm or other nominee. You must provide voting instructions by filling out the voting instruction card in order for your shares to be voted. If you have any questions or need assistance voting your shares of Streamline common stock, please contact Alliance Advisors, LLC, our proxy solicitor (“Alliance Advisors”), by calling toll-free at 1-844-202-7145.

The accompanying Notice of Special Meeting of Stockholders and proxy statement provide detailed information about the Special Meeting, the Merger Agreement, the Merger, and the proposals to be voted on at the Special Meeting. A copy of the Merger Agreement is attached as Annex A to the proxy statement. The Notice of Special Meeting of Stockholders and proxy statement are also available at http://www.envisionreports.com/STRM-SPC for record stockholders of the Company and at www.edocumentview.com/STRM-SPC for beneficial stockholders of the Company and the general public. Please carefully read the entire proxy statement and the annexes and documents included in, or incorporated by reference into, the proxy statement. You may also obtain more information about Streamline from the documents Streamline files with the Securities and Exchange Commission, including those incorporated by reference into the accompanying proxy statement.

On behalf of the Streamline Board, thank you for your continued support.

Sincerely,

Wyche T. “Tee” Green, III
Chairman of the Board

NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED THE MERGER, PASSED UPON THE MERITS OF THE MERGER AGREEMENT, THE MERGER OR THE OTHER TRANSACTIONS CONTEMPLATED BY THE MERGER AGREEMENT OR DETERMINED IF THE ACCOMPANYING PROXY STATEMENT IS ACCURATE OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

PLEASE COMPLETE, SIGN, DATE AND RETURN THE ENCLOSED PROXY CARD PROMPTLY. The accompanying proxy statement is dated July 10, 2025 and, together with the enclosed form of proxy card, is first being mailed to Streamline stockholders on or about July 10, 2025.

Table of Contents

STREAMLINE HEALTH SOLUTIONS, INC.

2400 Old Milton Pkwy, P.O. Box 1353

Alpharetta, GA 30009

NOTICE OF SPECIAL MEETING OF STOCKHOLDERS

TO BE HELD ON AUGUST 7, 2025

To the Stockholders of Streamline Health Solutions, Inc.:

Notice is hereby given that the Special Meeting of Stockholders of Streamline Health Solutions, Inc. (“Streamline” or the “Company”) will be held virtually via live webcast on August 7, 2025, at 9:00 a.m. Eastern Time, at https://meetnow.global//MJHXM7U (including any adjournments or postponements thereof, the “Special Meeting”). For purposes of attendance at the Special Meeting, all references in this proxy statement to “present” shall mean virtually present at the Special Meeting. The Special Meeting is being held for the following purposes:

PROPOSAL 1—To adopt the Agreement and Plan of Merger, dated as of May 29, 2025 (as it may be amended from time to time, the “Merger Agreement”), by and among Streamline, Mist Holding Co., a Delaware corporation and the parent company of Hayes Management Consulting LLC d/b/a MDaudit (“Parent” and, together with its affiliates, “MDaudit”), and MD BE Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”), pursuant to which, and upon the terms and subject to the conditions set forth therein, Merger Sub will be merged with and into Streamline, with Streamline continuing as the surviving corporation and becoming a wholly owned subsidiary of Parent (such merger, the “Merger” and such proposal, the “Merger Proposal”).

PROPOSAL 2—To approve, on a non-binding, advisory basis, certain compensation that may be paid or become payable to Streamline’s named executive officers in connection with the Merger (the “Compensation Proposal”).

PROPOSAL 3—To approve the adjournment of the Special Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes present or represented by proxy at the Special Meeting to approve the Merger Proposal (the “Adjournment Proposal”).

Only stockholders of record at the close of business on June 23, 2025 (the “Record Date”), will be entitled to notice of, and to vote at, the Special Meeting and any adjournment or postponement thereof.

The proxy statement of which this notice is a part (a) incorporates important business and financial information about Streamline from other documents that Streamline has filed with the U.S. Securities and Exchange Commission (the “SEC”) and that are contained in or incorporated by reference into this proxy statement and (b) provides a detailed description of the Merger and the Merger Agreement and the other matters to be considered at the Special Meeting, including the proposals listed above. Please refer to the accompanying proxy statement, including the Merger Agreement and the other annexes and documents included in, or incorporated by reference into, the accompanying proxy statement for further information with respect to the business to be transacted at the Special Meeting. You are encouraged to read the entire proxy statement carefully before voting.

The Board of Directors of the Company (the “Streamline Board”) has unanimously (i) approved and declared advisable the Merger Agreement and the transactions contemplated by the Merger Agreement, including the Merger, (ii) determined that the Merger Agreement and the transactions contemplated by the Merger Agreement, including the Merger, are fair to, and in the best interests of Streamline and the holders of shares of Streamline common stock, (iii) recommended that holders of shares of Streamline common stock adopt the Merger Agreement at the Special Meeting, and (iv) directed that the Merger Agreement be submitted to the holders of shares of Streamline common stock for adoption at the Special Meeting.

Under Section 262 of the General Corporation Law of the State of Delaware (the “DGCL”), holders of Streamline common stock who do not vote in favor of the Merger Proposal will have the right to seek appraisal and obtain payment in cash for the fair value of their shares of Streamline common stock, as determined by the Court of Chancery of the State of Delaware if the Merger is completed, but only if they strictly comply with the procedures set forth in Section 262 of the DGCL. These procedures are summarized in the section titled “Appraisal Rights of Streamline Stockholders” beginning on page 54 of the accompanying proxy statement. In addition, the text of Section 262 of the DGCL is attached as Annex D to the accompanying proxy statement.

YOUR VOTE IS VERY IMPORTANT, REGARDLESS OF THE NUMBER OF SHARES OF STREAMLINE COMMON STOCK THAT YOU OWN.

Table of Contents

Streamline and Parent cannot complete the Merger without the approval of the Merger Proposal by at least two-thirds (66 2/3%) of the issued and outstanding shares of Streamline common stock entitled to vote on the Merger Proposal. The failure of any Streamline stockholder to vote and any abstentions from voting on the Merger Proposal will have the same effect as a vote “AGAINST” the Merger Proposal.

Whether or not you plan to participate in the Special Meeting, Streamline urges you to submit a proxy in advance of the Special Meeting to have your shares voted by using one of the methods described in the accompanying proxy statement. If your shares are held in “street name” by a bank, brokerage firm or other nominee, please follow the instructions on the voting instruction card furnished by such bank, brokerage firm or other nominee. You must provide voting instructions by filling out the voting instruction card in order for your shares to be voted. Any stockholder of record participating in the Special Meeting may vote at the Special Meeting even if such stockholder has returned a proxy card. However, if your shares are held in “street name” you must obtain a “legal proxy” from the bank, brokerage firm or other nominee to vote at the Special Meeting.

If you have any questions about the Special Meeting, the Merger Agreement, the Merger, the proposals to be voted on at the Special Meeting or the accompanying proxy statement, would like additional copies of this proxy statement, need to obtain proxy cards or other information related to this proxy solicitation or need help submitting a proxy or voting your shares of Streamline common stock, you should contact:

Streamline Health Solutions, Inc.

2400 Old Milton Pkwy, P.O. Box 1353

Alpharetta, GA 30009

Attention: Corporate Secretary

(888) 997-8732

Alliance Advisors, LLC

150 Clove Rd #400

Little Falls Township, NJ 07424
Call Toll Free: 1-844-202-7145

By Order of the Streamline Board,

Bryant J. Reeves, III

Chief Financial Officer

Atlanta, Georgia July 10, 2025

A proxy statement and proxy card are included herewith. As a stockholder, you are urged to vote. See “General Information—Voting Methods” in the included proxy statement for more information on your voting options. It is important that your shares be voted. In order to avoid the additional expense of further solicitation, we ask your cooperation in voting promptly.

IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE SPECIAL MEETING OF STOCKHOLDERS TO BE HELD ON AUGUST 7, 2025.

Our Notice of Special Meeting of Stockholders, proxy statement for the Special Meeting of Stockholders and 2025 Annual Report to Stockholders are available at http://www.envisionreports.com/STRM-SPC for record stockholders of Streamline and at www.edocumentview.com/STRM-SPC for beneficial stockholders of Streamline and the general public.

Table of Contents

TABLE OF CONTENTS

SUMMARY	1
QUESTIONS AND ANSWERS	9
CAUTIONARY STATEMENT REGARDGING FORWARD-LOOKING STATEMENTS	18
INFORMATION ABOUT THE COMPANIES	19
THE SPECIAL MEETING	20
Date, Time and Place of the Special Meeting	20
Pre-Registering for the Special Meeting	20
Purposes of the Special Meeting	20
Recommendation of the Streamline Board	20
Outstanding Shares as of the Record Date	20
Record Date; Stockholders Entitled to Vote	21
Quorum and Broker Non-Votes	21
Required Vote	21
Treatment of Abstentions and Failure to Vote	22
Shares and Voting of Streamline’s Directors and Executive Officers	22
How to Vote or Have Your Shares Voted	22
Revocation of Proxies	23
Shares Held in Name of Broker	24
Tabulation of Votes	24
Solicitation of Proxies	24
Householding of Special Meeting Materials	24
Adjournments	24
Questions and Additional Information	24
THE MERGER	25
Effects of the Merger	25
Expected Timing of the Merger	25
Effect on Streamline if the Merger is Not Completed	25
Merger Consideration	26
Background of the Merger	27
Recommendation of the Streamline Board and Reasons for the Merger	34
Opinion of the Streamline Board’s Financial Advisor	39
Certain Unaudited Prospective Financial Information	44
Interests of Streamline’s Directors and Executive Officers in the Merger	48
Financing of the Merger	54
Regulatory Matters	54
Delisting and Deregistration of Streamline Common Stock	54
Appraisal Rights of Streamline Stockholders	54

THE MERGER AGREEMENT	55
Explanatory Note Regarding the Merger Agreement	55
Structure of the Merger; Certificate of Incorporation; Bylaws; Directors and Officers	55
Timing of Closing; Effective Time	56
Effect of the Merger on Streamline Common Stock	56
Treatment of Streamline Equity Awards	57
Treatment of Streamline Warrants	57
Surrender and Payment Procedures	57
Lost, Stolen or Destroyed Share Certificates	58

Table of Contents

Rights of Streamline Stockholders Following the Effective Time; Transfers Following the Effective Time	58
Withholding Rights	58
Representations and Warranties	59
Conduct of Businesses of Streamline Prior to Completion of the Merger	62
Conduct of Business of Parent Prior to Completion of the Merger	64
Stockholder Meeting and Board Recommendation	64
No Solicitation of Other Offers by Streamline	65
Change of Recommendation; Match Rights	67
Efforts; Cooperation; Antitrust Matters	69
Employee Benefits	70
Directors’ and Officers’ Indemnification and Insurance	71
Financing Cooperation	72
Other Covenants	72
Conditions to the Merger	73
Termination of the Merger Agreement	74
Termination Fee and Expenses	75
Effect of Termination	75
Specific Performance	76
Fees and Expenses	76
Amendments and Waivers	76
Governing Law and Venue; Waiver of Jury Trial	76

THE VOTING AGREEMENTS	77
APPRAISAL RIGHTS OF STREAMLINE STOCKHOLDERS	78
How to Exercise and Perfect Your Appraisal Rights	78
Who May Exercise Appraisal Rights	79
Written Demand and Notice	79
Judicial Appraisal	80
Withdrawal	81
PROPOSAL 1—APPROVAL OF THE MERGER PROPOSAL	82
The Merger Proposal	82
Vote Required for Approval	82
Recommendation of the Streamline Board	82
PROPOSAL 2—APPROVAL OF THE COMPENSATION PROPOSAL	83
The Compensation Proposal	83
Vote Required for Approval	83
Recommendation of the Streamline Board	83
PROPOSAL 3—APPROVAL OF THE ADJOURNMENT PROPOSAL	84
The Adjournment Proposal	84
Vote Required for Approval	84
Recommendation of the Streamline Board	84
MARKET PRICES AND DIVIDEND DATA	85
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT	86
MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE MERGER	88
U.S. Holders	89
Non-U.S. Holders	89
Information Reporting and Backup Withholding	90
FUTURE STOCKHOLDER PROPOSALS	91
WHERE YOU CAN FIND MORE INFORMATION	92
MISCELLANEOUS	93
Annex A - The Merger Agreement	A-1
Annex B—Form of Voting Agreement	B-1
Annex C—Opinion of Cain Brothers	C-1
Annex D—Section 262 of the DGCL	D-1

Table of Contents

SUMMARY

This summary highlights information contained elsewhere in this proxy statement. We urge you to read carefully the remainder of this proxy statement, including the attached annexes, the documents incorporated by reference into this proxy statement and the other documents to which we have referred you because this section does not provide all the information that might be important to you with respect to the Merger, the Merger Agreement and the related matters being considered at the Special Meeting (as each such capitalized term is defined below). See also the section titled “Where You Can Find More Information” on page 92. We have included page references to direct you to a more complete description of the topics presented in this summary. In this proxy statement, the terms “Streamline,” “the Company,” “we,” “our” and “us” refer to Streamline Health Solutions, Inc. and its wholly owned subsidiaries taken as a whole, unless the context requires otherwise.

Information About the Companies (Page 19)

Streamline Health Solutions, Inc.

2400 Old Milton Pkwy

P.O. Box 1353

Alpharetta, Georgia 30009

(888) 997-8732

Streamline Health Solutions, Inc. is a Delaware corporation that enables healthcare organizations to proactively address revenue leakage and improve financial performance. Streamline delivers integrated solutions, technology-enabled services and analytics that drive compliant revenue leading to improved financial performance across the enterprise. The common stock, par value $0.01 per share, of the Company (“Streamline common stock”) is listed on The Nasdaq Capital Market (“Nasdaq”) under the symbol “STRM.”

Additional information about Streamline is included in the documents incorporated by reference into this proxy statement. See the section titled “Where You Can Find More Information” beginning on page 92 of this proxy statement.

Mist Holding Co.

c/o MDaudit

800 Lexington St., Waltham Plaza #1038

Waltham, Massachusetts 02452

(617) 559-0404

Mist Holding Co. (“Parent” and, together with its affiliates, “MDaudit”) is a Delaware corporation. Parent is a holding company that conducts substantially all activities through its wholly owned subsidiary, Hayes Management Consulting LLC, a Massachusetts limited liability company doing business as “MDaudit.” MDaudit is a leading healthcare technology provider that partners with the nation’s premier healthcare systems to reduce compliance risk, improve efficiency, retain revenue, and enhance communication between cross-functional teams. Bringing solutions to an industry in transformation, MDaudit enables organizations to minimize billing risks and maximize revenue with an AI-powered, integrated, cloud-based platform that leverages the power of collaboration between people and sophisticated technology to keep humans at the forefront of decision-making while driving sustainable change.

MD BE Merger Sub, Inc.

c/o MDaudit

800 Lexington St., Waltham Plaza #1038

Waltham, Massachusetts 02452

(617) 559-0404

MD BE Merger Sub, Inc. (“Merger Sub”) is a Delaware corporation and a wholly owned subsidiary of Parent. Merger Sub was incorporated by Parent solely in contemplation of the transactions contemplated by the Agreement and Plan of Merger, dated as of May 29, 2025 (as it may be amended from time to time, the “Merger Agreement”), by and among Streamline, Parent, and Merger Sub, pursuant to which, and upon the terms and subject to the conditions set forth therein, Merger Sub will be merged with and into Streamline, with Streamline continuing as the surviving corporation and becoming a wholly owned subsidiary of Parent (the “Merger”). Merger Sub has not conducted any business and has no assets, liabilities, or obligations of any nature other than as set forth in the Merger Agreement. Upon completion of the Merger, Merger Sub will cease to exist and Streamline will continue as the surviving corporation (the “surviving corporation”).

Table of Contents

Merger Agreement (Page 55)

A copy of the Merger Agreement is attached as Annex A to this proxy statement. Streamline encourages you to read the entire Merger Agreement carefully because it is the principal document governing the Merger. For more information on the Merger Agreement, see the section titled “The Merger Agreement” beginning on page 55 of this proxy statement.

Effects of the Merger (Page 25)

Upon the terms and subject to the conditions of the Merger Agreement and in accordance with Delaware law, Merger Sub will merge with and into Streamline, whereupon the separate existence of Merger Sub will cease, and Streamline will survive the Merger as a wholly-owned subsidiary of MDaudit.

Merger Consideration (Page 26)

At the effective time of the Merger (the “Effective Time”), each share of Streamline common stock issued and outstanding immediately prior to the Effective Time (other than any dissenting shares or other excluded shares, as further described below) will automatically be cancelled and converted into the right to receive $5.34 per share in cash, without interest (the “Merger Consideration”).

Any shares of Streamline common stock held by holders who have not voted in favor of the adoption of the Merger Agreement (or consented thereto in writing) and who are entitled to demand, and who have perfected a demand, for appraisal rights of such shares in accordance with Section 262 of the General Corporation Law of the State of Delaware (the “DGCL”) are considered “dissenting shares” and will not be converted into the right to receive the Merger Consideration, but instead will be entitled to only such rights as are granted by Section 262 of the DGCL. Any shares of Streamline common stock held by the Company as treasury stock and not held on behalf of third parties, and any shares of Streamline common stock owned by Parent, Merger Sub or any direct or indirect wholly owned subsidiary of Parent or Merger Sub (which, together with any dissenting shares, are considered “excluded shares”) will be cancelled for no consideration.

For additional information on the Merger Consideration and the treatment of Streamline common stock in connection with the Merger, see the section titled “The Merger Agreement—Effect of the Merger on Streamline Common Stock” beginning on page 56 of this proxy statement.

Treatment of Streamline Equity Awards (Pages 49 and 57)

At the Effective Time, each restricted stock award corresponding to shares of Streamline common stock granted under the Company’s equity plans (each, a “Company Restricted Share”) that is outstanding and unvested as of the Effective Time will automatically be cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of Streamline common stock corresponding to such Company Restricted Shares immediately prior to the Effective Time, multiplied by (ii) the Merger Consideration, less applicable withholding taxes.

At the Effective Time, each option to purchase shares of Streamline common stock granted under the Company’s equity plans (each, a “Company Option”) that is outstanding and unexercised as of the Effective Time (whether vested or unvested) and has a per share exercise price that is less than the Merger Consideration will automatically be cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of Streamline common stock subject to such Company Option immediately prior to the Effective Time, multiplied by (ii) the excess of the Merger Consideration over the exercise price per share of Streamline common stock subject to such Company Option, less applicable withholding taxes. Each Company Option that is outstanding and unexercised as of the Effective Time (whether vested or unvested) and has a per share exercise price that is equal to or greater than the Merger Consideration will automatically be cancelled for no consideration. As of the date of this proxy statement, each outstanding Company Option was “out of the money” because it has a per share exercise price that is equal to or greater than the Merger Consideration and will be cancelled at the Effective Time for no consideration.

For additional information on the treatment of Streamline equity awards in connection with the Merger, see the sections titled “The Merger Agreement—Treatment of Streamline Equity Awards” and “The Merger—Interests of Streamline’s Directors and Executive Officers in the Merger—Treatment of Streamline Equity Awards.”

Treatment of Streamline Warrants (Page 57)

At the Effective Time, each warrant to purchase shares of Streamline common stock (each, a “Company Warrant”) that is outstanding and unexercised as of the Effective Time and has a per share exercise price that is less than the Merger Consideration will be cancelled and converted into the right to receive a cash payment equal to (i) the number of shares of Streamline common stock subject to the Company Warrant immediately prior to the Effective Time, multiplied by (ii) the excess of the Merger Consideration over the exercise price per share of Streamline common stock subject to such Company Warrant, less applicable withholding taxes. Each Company Warrant that is outstanding and unexercised as of the Effective Time and has a per share exercise price that is equal to or greater than the Merger Consideration will be cancelled for no consideration. As of the date of this proxy statement, each outstanding Company Warrant was “out of the money” because it has a per share exercise price that is equal to or greater than the Merger Consideration and will be cancelled at the Effective Time for no consideration.

For additional information on the treatment of Streamline warrants in connection with the Merger, see the sections titled “The Merger Agreement—Treatment of Streamline Warrants” and “The Merger—Interests of Streamline’s Directors and Executive Officers in the Merger—Treatment of Streamline Warrants.”

Table of Contents

Streamline Special Meeting (Page 20)

Purposes of the Special Meeting

A Special Meeting of Stockholders of the Company will be held virtually on August 7, 2025, at 9:00 a.m. Eastern Time (including any adjournments or postponements thereof, the “Special Meeting”). At the Special Meeting, Streamline stockholders will be asked to vote upon the following proposals:

●

to adopt the Merger Agreement, pursuant to which Merger Sub will be merged with and into Streamline, with Streamline continuing as the surviving corporation and becoming a wholly owned subsidiary of Parent (the “Merger Proposal”);

●

to approve, on a non-binding, advisory basis, certain compensation that may be paid or become payable to Streamline’s named executive officers in connection with the Merger (the “Compensation Proposal”); and

●

to approve the adjournment of the Special Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes present or represented by proxy at the Special Meeting to approve the Merger Proposal (the “Adjournment Proposal”).

In accordance with Streamline’s Amended and Restated Bylaws, dated March 28, 2014 (the “Bylaws”), the only business that will be brought before the Special Meeting are the Merger Proposal, the Compensation Proposal and the Adjournment Proposal, as stated in the accompanying notice of the Special Meeting.

Record Date

The record date for the determination of stockholders entitled to notice of and to vote at the Special Meeting is June 23, 2025 (the “Record Date”). Only Streamline stockholders who held shares of record as of the close of business on the Record Date are entitled to receive notice of, and vote at, the Special Meeting and any adjournment or postponement of the Special Meeting. Streamline’s official stock ownership records will conclusively determine whether a stockholder is a “holder of record” as of the Record Date.

Required Vote

●

Proposal 1—The Merger Proposal. The affirmative vote of at least two-thirds (66 2/3%) of the issued and outstanding shares of Streamline common stock entitled to vote thereon is required to approve the Merger Proposal.

●

Proposal 2—The Compensation Proposal. The affirmative vote of a majority of the shares of Streamline common stock present or represented by proxy at the Special Meeting and entitled to vote thereon is required to approve (on a non-binding, advisory basis) the Compensation Proposal.

●

Proposal 3—The Adjournment Proposal. The affirmative vote of a majority of the shares of Streamline common stock present or represented by proxy at the Special Meeting and entitled to vote thereon is required to approve the Adjournment Proposal.

For more information, see the section titled “The Special Meeting—Required Vote; Treatment of Abstentions and Failure to Vote.”

Recommendation of the Streamline Board and Reasons for the Merger (Page 34)

At its May 28, 2025 meeting held to evaluate the Merger, the Board of Directors of the Company (the “Streamline Board”) unanimously (i) approved and declared advisable the Merger Agreement and the transactions contemplated by the Merger Agreement, including the Merger; (ii) determined that the Merger Agreement and the transactions contemplated by the Merger Agreement, including the Merger, are fair to, and in the best interests of, the Company and the holders of the shares of Streamline common stock; (iii) recommended that the holders of shares of Streamline common stock adopt the Merger Agreement at the Special Meeting; and (iv) directed that the Merger Agreement be submitted to the holders of shares of Streamline common stock for their adoption at the Special Meeting. Accordingly, the Streamline Board recommends that Streamline stockholders vote “FOR” the Merger Proposal, “FOR” the Compensation Proposal, and “FOR” the Adjournment Proposal.

In evaluating the Merger Agreement and arriving at its determination, the Streamline Board held a number of meetings, consulted with Streamline’s management, the Streamline Board’s financial advisor, Cain Brothers, a division of KeyBanc Capital Markets Inc. (“Cain Brothers”), and Streamline’s outside legal counsel, Troutman Pepper Locke LLP, and considered a number of substantive factors, both positive and negative, and potential benefits and detriments of the Merger to Streamline and Streamline stockholders, as described in more detail in the section titled “The Merger—Recommendation of the Streamline Board and Reasons for the Merger.”

Table of Contents

Opinion of the Streamline Board’s Financial Advisor (Page 39)

On May 28, 2025, Cain Brothers rendered an oral opinion to the Streamline Board, which was subsequently confirmed in a written opinion as of the same date, as to the fairness, from a financial point of view, to the holders of Streamline common stock (other than Parent or any affiliate of Parent) of the Merger Consideration to be received by such holders pursuant to the Merger Agreement, based upon and subject to the various limiting conditions, qualifications, assumptions and other matters set forth therein with respect to the review undertaken by Cain Brothers.

The full text of Cain Brothers’ written opinion, dated May 28, 2025, is attached to this proxy statement as Annex C and incorporated by reference herein. You should read Cain Brothers’ opinion carefully and in its entirety for a discussion of, among other things, the scope of the review undertaken and the assumptions made, procedures followed, matters considered and qualifications and limitations with respect to the review undertaken by Cain Brothers in connection with its opinion. This summary is qualified in its entirety by reference to the full text of the opinion. Cain Brothers’ opinion was prepared for the use of the Streamline Board and addressed only the fairness from a financial point of view, as of the date of the opinion, of the Merger Consideration to be received by the holders of Streamline common stock (other than Parent or any affiliate of Parent) pursuant to the Merger Agreement. It does not constitute advice or a recommendation as to how any holders of Streamline common stock should vote with respect to the Merger or any other matter and does not in any manner address the price at which shares of Streamline common stock will trade at any time, if ever.

For further discussion of Cain Brother’s opinion, see the section titled “The Merger—Opinion of the Streamline Board’s Financial Advisor”.

Financing of the Merger (Page 54)

The consummation of the Merger is not conditioned upon receipt of financing by Parent. Parent has represented in the Merger Agreement that it has sufficient unrestricted cash on hand or other sources of immediately available funds to enable it to consummate the transactions contemplated by the Merger Agreement and pay the Merger Consideration under the Merger Agreement in accordance with the terms and conditions of the Merger Agreement and to make all other necessary payments of fees and expenses in connection with the transactions contemplated by the Merger Agreement.

Delisting and Deregistration of Streamline Common Stock (Page 54)

When the Merger is completed, the Streamline common stock will be delisted from Nasdaq and will be deregistered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). As a result, following the Merger and such deregistration, we will no longer file periodic reports with the SEC.

Material U.S. Federal Income Tax Consequences of the Merger (Page 88)

The receipt of cash in exchange for Streamline common stock pursuant to the Merger generally will be a taxable transaction for U.S. federal income tax purposes. U.S. Holders (as defined below under “Material U.S. Federal Income Tax Consequences of the Merger—U.S. Holders”) generally will recognize gain or loss for U.S. federal income tax purposes in an amount equal to the difference, if any between (a) the amount of cash received and (b) the U.S. Holder’s adjusted tax basis in the Streamline common stock surrendered in exchange.

Except in certain specific circumstances described below under “Material U.S. Federal Income Tax Consequences of the Merger—Non-U.S. Holders,” a Non-U.S. Holder (as defined below under “Material U.S. Federal Income Tax Consequences of the Merger—Non-U.S. Holders”) generally will not be subject to U.S. federal income tax unless such Non-U.S. Holder has certain connections with the United States.

The U.S. federal income tax consequences described above may not apply to all holders of Streamline common stock. You should read the section titled “Material U.S. Federal Income Tax Consequences of the Merger” for a more complete discussion of the U.S. federal income tax consequences of the Merger to you. Tax matters are complicated and the tax consequences of the Merger to you will depend on your particular tax situation. You should consult your tax advisor to determine the applicable U.S. federal, state, local and non-U.S. tax consequences of the Merger to you.

Table of Contents

Expected Timing of the Merger (Page 25)

In order to complete the Merger, Streamline must obtain stockholder approval of the Merger Proposal described in this proxy statement and the other conditions to the closing of the Merger (the “Closing”) under the Merger Agreement must be satisfied or waived. The parties to the Merger Agreement currently expect to complete the Merger in the third quarter of 2025, although none of the parties can assure completion by any particular date, if at all. It is possible, including as a result of factors outside the control of the parties to the Merger Agreement, that the Merger will be consummated at a later time or not at all.

For more information on the conditions to Closing, see the section titled “The Merger Agreement—Conditions to the Merger.”

Conditions to the Merger (Page 73)

Each party’s obligation to effect the Merger is subject to the satisfaction or waiver of certain customary conditions, including: (i) the adoption of the Merger Agreement by the holders of at least two-thirds (66 2/3%) of the issued and outstanding shares of Streamline common stock entitled to vote thereon (which condition is not waivable); and (ii) the absence of any law or order issued by any court or other governmental authority of competent jurisdiction restraining, enjoining, rendering illegal, or otherwise preventing the consummation of the Merger.

In addition, the obligations of Parent and Merger Sub to effect the Merger are subject to the satisfaction or waiver by Parent of the following conditions: (i) the accuracy of the representations and warranties of Streamline contained in the Merger Agreement (subject to certain materiality qualifications); (ii) Streamline’s performance in all material respects with all of the obligations required to be performed by it under the Merger Agreement prior to the date of the Closing (the “Closing Date”); (iii) the absence of a “Material Adverse Effect” (as described in the section of this proxy statement titled “The Merger Agreement—Representations and Warranties”) since the date of the Merger Agreement; and (iv) the delivery of an officer’s certificate by Streamline certifying that the foregoing three conditions have been satisfied.

The obligation of Streamline to effect the Merger is also subject to the satisfaction or waiver by Streamline of the following conditions: (i) the accuracy of the representations and warranties of Parent and Merger Sub contained in the Merger Agreement (subject to certain materiality qualifications); (ii) Parent’s and Merger Sub’s performance in all material respects with all of the obligations required to be performed by them under the Merger Agreement prior to the Closing Date; and (iii) the delivery of an officer’s certificate by Parent and Merger Sub certifying that the foregoing two conditions have been satisfied.

Consummation of the Merger is not subject to any financing condition. For more information on the conditions to Closing, see the section titled “The Merger Agreement—Conditions to the Merger.”

No Solicitation of Other Offers by Streamline (Page 65)

As more fully described in this proxy statement and in the Merger Agreement, during the period from the date of the Merger Agreement and until the earlier of the Effective Time or the date the Merger Agreement is terminated, Streamline has agreed not to directly or indirectly, (i) initiate, solicit, propose or knowingly encourage or knowingly facilitate any inquiries or proposals that constitute an acquisition proposal, (ii) engage in any discussions or negotiations regarding, or provide any nonpublic information or data relating to, an acquisition proposal, (iii) furnish to any third person any non-public information with the intent to induce an acquisition proposal, or (iv) approve, endorse or recommend any proposal that constitutes, or would reasonably be expected to lead to, an acquisition proposal, subject to customary exceptions.

Prior to approval of the Merger Proposal by the Streamline stockholders, in the event Streamline receives a bona fide written acquisition proposal that did not result from a breach of Streamline’s non-solicitation and related obligations and the Streamline Board determines in good faith based on information then available and after consultation with its financial advisor and outside legal counsel that (i) such acquisition proposal constitutes, or is reasonably likely to result in, a superior proposal and (ii) failure to take such action would be reasonably likely to be inconsistent with its fiduciary obligations to the Streamline stockholders under applicable law, Streamline may provide information to, and engage or participate in discussions or negotiations with, the person making the acquisition proposal, subject to complying with certain notice requirements and other specified conditions.

For more information on Streamline’s non-solicitation obligations, including information on what constitutes an “acquisition proposal” and a “superior proposal” for purposes of the Merger Agreement, see the section titled “The Merger Agreement—No Solicitation of Other Offers by Streamline.”

Table of Contents

Changes in Board Recommendation (Page 67)

Subject to certain exceptions described below, the Streamline Board is required to recommend that Streamline stockholders vote in favor of the Merger Proposal and may not change such recommendation in a manner adverse to Parent.

Prior to the approval of the Merger Proposal by the Streamline stockholders, the Streamline Board may make an adverse recommendation change (i) in response to an acquisition proposal, if the Streamline Board determines in good faith, after consultation with its financial advisor and outside legal counsel, that the acquisition proposal constitutes a superior proposal and that the failure to take such action would be reasonably likely to be inconsistent with its fiduciary obligations under applicable law, or (ii) in response to an intervening event, if the Streamline Board determines in good faith, after consultation with its financial advisor and outside legal counsel, that the failure to take such action would be reasonably likely to be inconsistent with its fiduciary obligations under applicable law, subject to complying with certain procedural requirements. These requirements include:

●

In the case of a superior proposal, Streamline must give five business days’ prior written notice to Parent that Streamline received such acquisition proposal and intends to make an adverse recommendation change, and during such five business day period, Streamline must participate in good faith negotiations with Parent should Parent propose to make adjustments or revisions to the terms and conditions of the Merger Agreement. After such five business day period, prior to making an adverse recommendation change, the Streamline Board must determine (taking into account any adjustment to the terms and conditions of the Merger Agreement proposed by Parent in writing in response to such acquisition proposal) in good faith, after consultation with its financial advisor and outside legal counsel, that the acquisition proposal remains a superior proposal and the failure of the Streamline Board to make such adverse recommendation change would be reasonably likely to be inconsistent with its fiduciary duties under applicable law. In the event of any change to the financial terms of, or any other material amendment or material modification to, any superior proposal, Streamline is required to deliver a new written notice to Parent and comply with the above requirements with respect to such new written notice, except that the five business day period above is reduced to two business days.

●

In the case of an intervening event, Streamline must give five business days’ prior written notice to Parent that an intervening event has occurred and that Streamline intends to make an adverse recommendation change, and during such five business day period, Streamline must participate in good faith negotiations with Parent to make such adjustments or revisions to the terms and conditions of the Merger Agreement in response thereto (to the extent Parent wishes to negotiate). After such five business day period, prior to making an adverse recommendation change, the Streamline Board must take into account any adjustments to the terms and conditions of the Merger Agreement proposed in writing by Parent and must determine in good faith, after consultation with its financial advisor and outside legal counsel, that the failure of the Streamline Board to make such adverse recommendation change in response to the intervening event would be reasonably likely to be inconsistent with its fiduciary duties under applicable law. In the event of any material changes regarding any intervening event, Streamline is required to deliver a new written notice to Parent and comply with the above requirements with respect to such new written notice, except that the five business day period above is reduced to two business days.

For more information on the Streamline Board’s ability to effect an adverse recommendation change, including information on the actions and events that constitute an “adverse recommendation change” or “intervening event” for purposes of the Merger Agreement, see the section titled “The Merger Agreement—Change of Recommendation; Match Rights”.

In the event that the Streamline Board is permitted by the Merger Agreement to effect an adverse recommendation change in response to a superior proposal, Streamline may also terminate the Merger Agreement to concurrently enter into an alternative acquisition agreement providing for such superior proposal if, prior to or concurrently with such termination, Streamline pays to Parent the termination fee of $950,000 (the “Termination Fee”) required to be paid to Parent as described in the section titled “The Merger Agreement—Termination Fee and Expenses.”

Termination of the Merger Agreement (Page 74)

Among other customary circumstances, either Parent or Streamline may terminate the Merger Agreement prior to the Effective Time if:

●

the Merger has not been consummated as of December 31, 2025 (the “Outside Date”);

●

the approval of the Merger Proposal by the Streamline stockholders is not obtained at the Special Meeting or at any postponement or adjournment thereof in accordance with the Merger Agreement; or

●

any court or other governmental authority of competent jurisdiction has enacted, issued, promulgated or entered any final and non-appealable law or order that permanently restrains, enjoins, renders illegal or otherwise permanently prohibits consummation of the Merger.

Table of Contents

Each of these mutual rights to terminate the Merger Agreement are generally not available to a party whose breach (and, in the case of Parent, including any breach by Merger Sub) of any representation, warranty, covenant or agreement set forth in the Merger Agreement has proximately caused the circumstance giving rise to the termination right.

Streamline may also terminate the Merger Agreement in other circumstances, including:

●

in response to certain breaches of the Merger Agreement by Parent or Merger Sub, subject to a cure period and certain other limitations; and

●

prior to the approval of the Merger Proposal by Streamline stockholders, to concurrently enter into an alternative acquisition agreement providing for a superior proposal, subject to Streamline’s compliance with its obligations regarding non-solicitation and adverse recommendation changes and payment of the Termination Fee.

Parent may also terminate the Merger Agreement in other circumstances, including:

●

in response to certain breaches of the Merger Agreement by Streamline, subject to a cure period and certain other limitations; and

●

if there has been an adverse recommendation change by the Streamline Board prior to the approval of the Merger Proposal by the Streamline stockholders.

The Merger Agreement may also be terminated by the mutual written consent of Parent and Streamline. For more details regarding the termination of the Merger Agreement, see the section titled “The Merger Agreement—Termination of the Merger Agreement.”

Termination Fee and Expenses (Page 75)

Streamline must pay Parent the Termination Fee if the Merger Agreement is terminated in certain circumstances, including:

●

if the Merger Agreement is terminated by Streamline to enter into an alternative acquisition agreement providing for a superior proposal;

●

if the Merger Agreement is terminated by Parent because of an adverse recommendation change by the Streamline Board;

●

if the Merger Agreement is terminated by either Streamline or Parent as a result of either the Merger not being consummated prior to the Outside Date or the failure to obtain the approval of the Merger Proposal by the Streamline stockholders, in each case, following an adverse recommendation change by the Streamline Board; and

●

if the Merger Agreement is terminated by Streamline or Parent under certain circumstances (as described in the section of this proxy statement titled “The Merger Agreement—Termination Fee and Expenses”), and within twelve months of such termination, Streamline consummates or enters into an alternative acquisition agreement with respect to an acquisition proposal for 50% or more of Streamline’s equity interests, or assets constituting 50% or more of the consolidated net revenue, net income or total assets of Streamline.

In no event will Streamline be required to pay the Termination Fee on more than one occasion.

The triggers for the Termination Fee are subject to additional conditions or qualifications, which are described in greater detail in the section titled “The Merger Agreement—Termination Fee and Expenses.”

Specific Performance (Page 76)

The Merger Agreement provides that the parties will be entitled to an injunction or injunctions, specific performance and other equitable relief to prevent breaches or threatened breaches of the Merger Agreement and to enforce specifically the performance of the terms and provisions thereof, including the right to cause each other party to consummate the Merger and the other transactions contemplated by the Merger Agreement.

For more information, see the section titled “The Merger Agreement—Specific Performance.”

Table of Contents

Voting Agreement (Page 77)

Concurrently with the execution of the Merger Agreement, certain officers and directors of Streamline and their respective affiliates (collectively, the “supporting stockholders”), entered into Voting and Support Agreements (each, a “Voting Agreement”) with Parent, pursuant to which the supporting stockholders agreed, among other things, to vote all shares of Streamline common stock owned by them (i) in favor of the Merger Proposal, the Adjournment Proposal and any other matters necessary for the consummation of the Merger, and (ii) against any alternative acquisition proposal from a third party, any action or proposal in furtherance of such an acquisition proposal, and any other actions that are intended to, or would reasonably be expected to, result in the conditions to Closing not being satisfied or a breach by Streamline of the Merger Agreement, change the capitalization of Streamline or the voting rights of Streamline’s securities, or otherwise impede, interfere with, delay, discourage, adversely affect or inhibit the timely consummation of the Merger, subject to certain termination rights set forth in the Voting Agreements. Nothing in the Voting Agreements will affect any actions taken by a supporting stockholder or any of such stockholder’s affiliates (or any officer, director or employee thereof) solely in his or her capacity as a director or officer of Streamline or from complying with his or her fiduciary obligations solely to the extent acting in such person’s capacity as a director or officer of Streamline. At the close of business on the Record Date, the supporting stockholders represented an aggregate of approximately 21.82% of the outstanding shares of Streamline common stock.

For more information regarding the Voting Agreements, please see the section titled “The Voting Agreements.” For more information regarding the security ownership of the supporting stockholders, please see the section of this proxy statement entitled “Security Ownership of Certain Beneficial Owners and Management.”

Appraisal Rights of Streamline Stockholders (Pages 54 and 78)

Streamline stockholders who do not vote in favor of approval of the Merger Proposal, who continuously hold their shares of Streamline common stock through the effective date of the Merger and who otherwise comply precisely with the applicable provisions of Section 262 of the DGCL will be entitled to seek appraisal of the fair value of their shares of Streamline common stock, as determined by the Delaware Court of Chancery, if the Merger is completed, in lieu of receiving the Merger Consideration in respect of such shares. The “fair value” of your shares of Streamline common stock as determined by the Delaware Court of Chancery could be greater than, the same as, or less than the value of the Merger Consideration that you would otherwise be entitled to receive under the terms of the Merger Agreement. Streamline stockholders who wish to exercise the right to seek an appraisal of their shares must so advise Streamline by submitting a written demand for appraisal in the form described in this proxy statement prior to the vote to approve the Merger Proposal and must otherwise follow the procedures prescribed by Section 262 of the DGCL. For further detail regarding appraisal rights, see the sections titled “The Merger Agreement—Effect of the Merger on Streamline Common Stock—Shares of Dissenting Stockholders” and “Appraisal Rights of Streamline Stockholders.”

The text of Section 262 of the DGCL is attached as Annex D to this proxy statement. You are encouraged to read these provisions carefully and in their entirety. Due to the complexity of the procedures for exercising appraisal rights, Streamline stockholders who are considering exercising such rights are encouraged to seek the advice of legal counsel and their financial advisors. Failure to strictly comply with these provisions may result in the loss of appraisal rights.

Interests of Streamline’s Directors and Executive Officers in the Merger (Page 48)

Streamline’s directors and executive officers may have interests in the Merger that may be different from, or in addition to, those of Streamline stockholders generally. These interests include, among others, (i) vesting of Company Restricted Shares held by certain of Streamline’s directors and officers, (ii) potential severance payments and benefits that certain Streamline directors and executive officers may become entitled to receive following the Effective Time upon a qualifying termination of employment, (iii) payments or bonuses that certain Streamline directors and executive officers may become entitled to receive following the Effective Time under individual bonus and employment agreements in an aggregate amount equal to $120,000, and (iv) rights to indemnification, advancement of expenses and directors’ and officers’ liability insurance that will survive the completion of the Merger. The Streamline Board was aware of and considered these interests, among other matters, in evaluating and negotiating the Merger Agreement and the Merger, in approving the Merger Agreement and the transactions contemplated by the Merger Agreement, and in recommending the approval of the Merger Proposal by the Streamline stockholders.

See the section titled “The Merger—Interests of Streamline’s Directors and Executive Officers in the Merger” for a more detailed description of these interests.

Market Prices of Streamline Common Stock (Page 85)

The Merger Consideration of $5.34 per share represents a 138% premium to Streamline’s closing price on May 28, 2025 (the last trading day prior to the public announcement of the Merger) and a 117% premium to Streamline’s 30-day volume weighted average stock price as of May 28, 2025. The closing price of Streamline common stock on Nasdaq on July 8, 2025, the most recent practicable date prior to the date of this proxy statement, was $5.20 per share. You are encouraged to obtain current market prices of Streamline common stock in connection with voting your shares of Streamline common stock.

Additional Information (Page 92)

You can find more information about Streamline in the periodic reports and other information we file with the U.S. Securities and Exchange Commission (the “SEC”). The information is available at the website maintained by the SEC at http://www.sec.gov.

Table of Contents

QUESTIONS AND ANSWERS

The following are some questions that you, as a Streamline stockholder, may have regarding the Merger and the Special Meeting and the answers to those questions. Streamline urges you to carefully read the remainder of this proxy statement because the information in this section does not provide all the information that might be important to you with respect to the Merger and the Special Meeting. Additional important information is also contained in the annexes to, and the documents incorporated by reference into, this proxy statement.

Q:	*What is the purpose of the Special Meeting?*

A:	At the Special Meeting, Streamline stockholders will consider and act upon the matters outlined in the notice of meeting accompanying this proxy statement, namely:

The Merger Proposal;

The Compensation Proposal; and

The Adjournment Proposal.

Q:	*Where and when is the Special Meeting?*

The Special Meeting will be held virtually on August 7, 2025, beginning at 9:00 a.m. Eastern Time, unless adjourned or postponed to a later date. There will not be a physical meeting location. Streamline stockholders of record as the close of business on the Record Date will be able to attend and vote at the Special Meeting by visiting https://meetnow.global/MJHXM7U and using the 15-digit control number located on their proxy cards. For purposes of attendance at the Special Meeting, all references in this proxy statement to “present” shall mean virtually present at the Special Meeting.

Q:	*How does the Streamline Board recommend that I vote on the proposals?*

A:	The Streamline Board unanimously recommends that Streamline stockholders vote “FOR” the Merger Proposal, “FOR” the Compensation Proposal, and “FOR” the Adjournment Proposal.

Q:	*How does the per share Merger Consideration compare to the market price of Streamline common stock prior to announcement of the Merger?*

Q:	*What will happen in the Merger?*

Upon the terms and subject to the conditions set forth in the Merger Agreement, Merger Sub will merge with and into Streamline, with Streamline surviving the Merger as a wholly owned subsidiary of Parent. After the Merger, Streamline common stock will be delisted from Nasdaq and deregistered under the Exchange Act, and, as a result, Streamline will no longer be a publicly held company.

Q:	*Who will own Streamline after the Merger?*

A:	Immediately following the Merger, Streamline will be a wholly owned subsidiary of Parent.

Q:	*What will I receive in the Merger?*

At the Effective Time, you will be entitled to receive $5.34 in cash, without interest, for each share of Streamline common stock that you hold, unless you have properly exercised and not failed to perfect, waived, withdrawn or otherwise lost your right to appraisal in accordance with Section 262 of the DGCL. You will not be entitled to receive shares in the surviving corporation or in Parent as a result of the Merger.

Table of Contents

Q:	*If a Streamline stockholder gives a proxy, how are the Streamline shares voted?*

Regardless of the method you choose to grant a proxy to vote your shares of Streamline common stock, the individuals named on the enclosed proxy card, or your proxies, will vote your shares of Streamline common stock in the way that you indicate. When completing the internet or telephone process or the proxy card, you may specify whether your shares of Streamline common stock should be voted “FOR” or “AGAINST” or to abstain from voting on the specific items of business to come before the Special Meeting.

If you properly sign your proxy card but do not mark the boxes showing how your shares of Streamline common stock should be voted on a matter, the shares represented by your properly signed proxy will be voted “FOR” the Merger Proposal, “FOR” the Compensation Proposal, and “FOR” the Adjournment Proposal.

Q:	*What will happen in the Merger to Streamline* *equity awards?*

At the Effective Time, each Company Restricted Share that is outstanding and unvested as of the Effective Time will automatically be cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of Streamline common stock corresponding to such Company Restricted Shares immediately prior to the Effective Time, multiplied by (ii) the Merger Consideration, less applicable withholding taxes.

At the Effective Time, each Company Option that is outstanding and unexercised as of the Effective Time (whether vested or unvested) and has a per share exercise price that is less than the Merger Consideration will automatically be cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of Streamline common stock subject to such Company Option immediately prior to the Effective Time, multiplied by (ii) the excess of the Merger Consideration over the exercise price per share of Streamline common stock subject to such Company Option, less applicable withholding taxes. Each Company Option that is outstanding and unexercised as of the Effective Time (whether vested or unvested) and has a per share exercise price that is equal to or greater than the Merger Consideration will automatically be cancelled at the Effective Time for no consideration. As of the date of this proxy statement, each outstanding Company Option was “out of the money” and will be cancelled for no consideration.

For additional information on the treatment of Streamline equity awards in connection with the Merger, see the section titled “The Merger Agreement—Treatment of Streamline Equity Awards” beginning on page 57 of this proxy statement and the section titled “The Merger—Interests of Streamline’s Directors and Executive Officers in the Merger—Treatment of Streamline Equity Awards” beginning on page 49 of this proxy statement.

Q:	*What will happen in the Merger to Streamline* *Warrants?*

At the Effective Time, each Company Warrant that is outstanding and unexercised as of the Effective Time and has a per share exercise price that is less than the Merger Consideration will be cancelled and converted into the right to receive a cash payment equal to (i) the number of shares of Streamline common stock subject to the Company Warrant immediately prior to the Effective Time, multiplied by (ii) the excess of the Merger Consideration over the exercise price per share of Streamline common stock subject to such Company Warrant, less applicable withholding taxes. Each Company Warrant that is outstanding and unexercised as of the Effective Time and has a per share exercise price that is equal to or greater than the Merger Consideration will be cancelled for no consideration. As of the date of this proxy statement, each outstanding Company Warrant was “out of the money” and will be cancelled for no consideration.

For additional information on the treatment of Streamline warrants in connection with the Merger, see the section titled “The Merger Agreement—Treatment of Streamline Warrants” beginning on page 57 of this proxy statement and the section titled “The Merger—Interests of Streamline’s Directors and Executive Officers in the Merger—Treatment of Streamline Warrants” beginning on page 51 of this proxy statement.

Q:	*Am I entitled to exercise appraisal rights instead of receiving the Merger Consideration for my shares of Streamline common stock?*

Yes. As a holder of record or beneficial owner of shares of Streamline common stock, you are entitled to appraisal rights under Section 262 of the DGCL in connection with the Merger if you follow the procedures and satisfy the conditions set forth in Section 262 of the DGCL. If you are considering exercising your appraisal rights, we encourage you to seek the advice of your own legal counsel. For additional information regarding appraisal rights, see the section titled “The Merger—Appraisal Rights of Streamline Stockholders” beginning on page 54 of this proxy statement. In addition, a copy of Section 262 of the DGCL is attached as Annex D to this proxy statement. Failure to strictly comply with Section 262 of the DGCL may result in your waiver of, or inability to, exercise appraisal rights.

Q:	*What vote is required to adopt the Merger Agreement?*

A:	The votes required for each proposal are as follows:

Table of Contents

Q:	*Do any of Streamline’s directors or officers have interests in the Merger that may differ from or be in addition to my interests as a stockholder?*

In considering the recommendation of the Streamline Board with respect to the Merger Agreement proposal, you should be aware that Streamline’s directors and executive officers have certain interests in the Merger that may be different from, or in addition to, the interests of Streamline stockholders generally. These interests include, among others, (i) vesting of Company Restricted Shares held by certain of Streamline’s directors and officers, (ii) potential severance payments and benefits that certain Streamline directors and executive officers may become entitled to receive following the Effective Time upon a qualifying termination of employment, (iii) payments or bonuses that certain Streamline directors and executive officers may become entitled to receive following the Effective Time under individual bonus and employment agreements in an aggregate amount equal to $120,000, and (iv) rights to indemnification, advancement of expenses and directors’ and officers’ liability insurance that will survive the completion of the Merger. The Streamline Board was aware of and considered these interests, among other matters, in evaluating and negotiating the Merger Agreement and the Merger, approving the Merger Agreement and the transactions contemplated by the Merger Agreement, and in recommending that the Merger Proposal be approved by the Streamline stockholders. For a description of the interests of Streamline’s directors and officers in the Merger, see the section titled “The Merger—Interests of Streamline’s Directors and Executive Officers in the Merger” beginning on page 48 of this proxy statement.

Q:	*When do you expect the Merger to be completed?*

In order to complete the Merger, Streamline must obtain stockholder approval of the Merger Proposal described in this proxy statement and the other closing conditions under the Merger Agreement must be satisfied or waived. The parties to the Merger Agreement currently expect to complete the Merger in the third quarter of 2025, although none of the parties can assure completion by any particular date, if at all. It is possible, including as a result of factors outside the control of the parties to the Merger Agreement, that the Merger will be consummated at a later time or not at all.

Q:	*What conditions must be satisfied to complete the Merger?*

Each party’s obligation to effect the Merger is subject to the satisfaction or waiver of certain customary conditions, including: (i) the adoption of the Merger Agreement by the holders of at least two-thirds (66 2/3%) of the issued and outstanding shares of Streamline common stock entitled to vote thereon (which condition is not waivable); and (ii) the absence of any law or order issued by any court or other governmental authority of competent jurisdiction restraining, enjoining, rendering illegal or otherwise preventing the consummation of the Merger.

In addition, the obligations of Parent and Merger Sub to effect the Merger are subject to the satisfaction or waiver by Parent of the following conditions: (i) the accuracy of the representations and warranties of Streamline contained in the Merger Agreement (subject to certain materiality qualifications); (ii) Streamline’s performance in all material respects with all of the obligations required to be performed by it under the Merger Agreement prior to the Closing Date; (iii) the absence of a “Material Adverse Effect” (as described in the section of this proxy statement titled “The Merger Agreement—Representations and Warranties”) since the date of the Merger Agreement; and (iv) the delivery of an officer’s certificate by Streamline certifying that the foregoing three conditions have been satisfied.

Table of Contents

Q:	Why am I being asked to consider and act upon a proposal to approve, on a non-binding, advisory basis, certain compensation that will or may be paid by Streamline to its named executive officers that is based on or otherwise relates to the Merger?

Section 14A of the Exchange Act and rules promulgated thereunder require Streamline to seek a non-binding, advisory vote to approve any agreements or understandings and compensation that will or may be paid by Streamline to its named executive officers that is based on or otherwise relates to the Merger. The approval of the Compensation Proposal by holders of Streamline common stock is not a condition to the completion of the Merger. Because the vote on the Compensation Proposal is advisory only, the vote will not be binding on either Streamline or Parent. Accordingly, if the Merger Proposal is approved and the Merger is completed, the compensation may be paid to Streamline’s named executive officers to the extent payable in accordance with the terms of the compensation agreements and arrangements even if holders of Streamline common stock fail to approve the advisory vote regarding the Compensation Proposal.

Q:	*Do you expect the Merger to be taxable to Streamline stockholders?*

Q:	*Who is entitled to vote at the Special Meeting?*

Only Streamline stockholders who held shares of record as of the close of business on the Record Date are entitled to receive notice of, and to vote at, the Special Meeting and any adjournment or postponement of the Special Meeting. Streamline’s official stock ownership records will conclusively determine whether a stockholder is a “holder of record” as of the Record Date. As of the close of business on the Record Date, there were 4,356,062 shares of Streamline common stock issued and outstanding. Each issued and outstanding share of Streamline common stock as of the close of business on the Record Date will entitle its holder to one vote on all matters to be voted on at the Special Meeting.

Q:	*Are there any Streamline stockholders who have already committed to voting in favor of any of the proposals at the Special Meeting?*

Yes. Concurrently with the execution of the Merger Agreement, in their respective capacities as record and beneficial owners of Streamline common stock, the supporting stockholders entered into Voting Agreements with Parent, pursuant to which the supporting stockholders agreed, among other things, to vote all shares of Streamline common stock owned by them in favor of the Merger Proposal, the Adjournment Proposal and any other matters necessary for the consummation of the Merger. The supporting stockholders include certain officers and directors of Streamline and their respective affiliates. At the close of business the Record Date, the supporting stockholders represented an aggregate of approximately 21.82% of the outstanding shares of Streamline common stock. For more information regarding the Voting Agreements, please see the section titled “The Voting Agreements” beginning on page 77 of this proxy statement. For more information regarding the security ownership of the supporting stockholders, please see the section titled “Security Ownership of Certain Beneficial Owners and Management” beginning on page 86 of this proxy statement.

Q:	*May I attend the Special Meeting and vote in person?*

All Streamline stockholders of record as of the close of business on the Record Date may attend and vote at the virtual Special Meeting by visiting https://meetnow.global/MJHXM7U and using the 15-digit control number located on their proxy cards. You will not be able to attend the Special Meeting physically in person. If you did not receive a 15-digit control number and wish to vote virtually at the Special Meeting, you should follow the instructions from your bank, brokerage firm or other nominee, including any requirement to obtain a legal proxy.

Table of Contents

Q:	*Who is soliciting my vote?*

The Streamline Board is soliciting your proxy, and Streamline will bear the expense of electronically hosting, printing and mailing proxy materials and soliciting proxies that we are seeking. In addition to the solicitation of proxies by mail, solicitation may be made by certain of our directors, officers, employees and agents, including, but not limited to, our proxy solicitor, Alliance Advisors, LLC (“Alliance Advisors”), in person, by telephone, or via electronic or facsimile transmission. Streamline has retained Alliance Advisors to assist in the solicitation of proxies on behalf of the Streamline Board for an estimated fee of $15,000 plus call center costs and reimbursement of reasonable expenses. Our directors, officers and other employees will receive no additional compensation for any such solicitations. We will request banks, brokerage firms and other nominees who hold shares of our common stock in their names to furnish proxy materials to beneficial owners of such shares, and we will reimburse such banks, brokerage firms and other nominees for the reasonable expenses incurred in forwarding the materials to such beneficial owners. Your cooperation in voting promptly will help to avoid additional expense. IF YOU NEED ASSISTANCE WITH THE VOTING OF YOUR SHARES, YOU MAY CONTACT ALLIANCE ADVISORS TOLL-FREE AT 1-844-202-7145.

Q:	*What do I need to do now?*

Streamline encourages you to carefully read this proxy statement, including all documents incorporated by reference into this proxy statement and the annexes to this proxy statement, in their entirety. After carefully reading and considering such information, please submit your proxy as soon as possible so that your shares of Streamline common stock will be represented and voted at the Special Meeting. Please follow the instructions set forth on the proxy card or on the voting instruction card provided by the record holder if your shares are held in “street name” by your bank, brokerage firm or other nominee.

Q:	*How do I vote if my shares are registered directly in my name?*

A:	If you are a stockholder of record (that is, if your Streamline shares are registered in your name with our transfer agent, Computershare Inc.) there are several ways for you to vote your shares of Streamline common stock at the Special Meeting.

●

By Mail. Streamline stockholders of record may vote their shares by signing, dating and mailing the enclosed proxy card using the enclosed postage prepaid envelope. We strongly encourage you, however, to consider using the internet or telephone voting options described below because these voting methods are faster and less costly than voting by mailing your signed and dated proxy card. If you vote via the internet or telephone, you do not need to mail your proxy card.

●

By Internet. Streamline stockholders of record may vote on the internet at http://www.envisionreports.com/STRM-SPC. Please have your proxy card available when going online and follow the online instructions. Stockholders that vote by internet must bear all costs associated with electronic access, including internet access fees. Internet voting for stockholders of record is available up until 11:59 p.m. Eastern Time on August 6, 2025, the day preceding the Special Meeting. The internet voting procedures are designed to authenticate each stockholder by use of a control number to allow stockholders to vote their shares and to confirm that their instructions have been properly recorded. The control number can be found on the enclosed proxy card.

●

By Telephone. Streamline stockholders of record also may vote by telephone by calling 1-800-652-8683 (toll-free) and using any touch-tone telephone to transmit their votes up until 11:59 p.m. Eastern Time on August 6, 2025, the day preceding the Special Meeting. Please have your proxy card in hand when you call and then follow the instructions. The control number necessary to vote your shares by telephone can be found on the enclosed proxy card.

●

During the Special Meeting. If you attend the virtual Special Meeting and wish to vote at the Special Meeting, you may vote through https://meetnow.global/MJHXM7U.

If you sign, date and return your proxy card without indicating how you wish to vote, your proxy will be voted “FOR” each of the Merger Proposal, the Adjournment Proposal, and the Compensation Proposal.

A control number, located on your proxy card, is designed to verify your identity and allow you to grant a proxy to vote your shares of Streamline common stock, and to confirm that your voting instructions have been properly recorded when granting a proxy electronically over the internet or by telephone. Please be aware that, although there is no charge for granting a proxy to vote your Streamline stock, if you grant a proxy electronically over the internet or by telephone, you may incur costs such as telephone and internet access charges for which you will be responsible. Even if you plan to attend the Special Meeting, you are strongly encouraged to grant a proxy to vote your shares of Streamline common stock.

If you hold your Streamline common stock in multiple accounts, you should vote your shares as described in each set of proxy materials you receive.

Q:	*How do I vote if my shares are held in the name of my broker (street name)?*

If your shares are held in “street name” by your bank, brokerage firm or other nominee, you must direct your bank, brokerage firm or other nominee on how to vote, and you will receive instructions from your bank, brokerage firm or other nominee describing how to vote your shares of Streamline common stock. The availability of internet or telephonic voting will depend on the nominee’s voting process. Please check with your bank, brokerage firm or other nominee and follow the voting procedures your bank, brokerage firm or other nominee provides.

Table of Contents

In accordance with the rules of Nasdaq, your bank, brokerage firm or other nominee can vote your shares of Streamline common stock on “routine” matters when they have not received voting instructions from you. However, such banks, brokerage firms and other nominees are precluded from exercising their voting discretion with respect to “non-routine” matters. If you are a beneficial owner and you do not provide these instructions, a “non-vote” occurs with respect to those matters. All proposals described in this proxy to be voted on at the Special Meeting are considered “non-routine” matters. Accordingly, if you are a beneficial holder and you do not provide your bank, brokerage firm or other nominee instructions on how to vote your shares of Streamline common stock at the Special Meeting, your bank, brokerage firm or other nominee generally will not be permitted to vote your shares on any of the proposals at the Special Meeting. If you are a beneficial holder, Streamline strongly encourages you to provide voting instructions to your bank, brokerage firm or other nominee so that your vote will be counted on all matters.

Q:	*Can I change my vote after I submit my proxy?*

A:	Yes. If you are a stockholder of record, you may change your vote or revoke your proxy by:

●

delivering a written notice of revocation of your proxy to Streamline’s Corporate Secretary at Streamline Health Solutions, Inc., 2400 Old Milton Pkwy, Box 1353, Alpharetta, GA 30009, Attention: Corporate Secretary, prior to the Special Meeting;

●

signing a new proxy card with a date later than the date of the previously submitted proxy card relating to the same shares of Streamline common stock and returning it to us by mail prior to the Special Meeting;

●

submitting a new proxy by telephone prior to 11:59 p.m. Eastern Time on August 6, 2025, the date preceding the Special Meeting;

●

submitting a new proxy by internet prior to 11:59 p.m. Eastern Time on August 6, 2025, the date preceding the Special Meeting; and

●

attending and voting at the Special Meeting.

Attendance at the Special Meeting, in and of itself, will not constitute a revocation of a proxy. Please note that if you want to revoke your proxy by mailing a new proxy card to Streamline or by sending a written notice of revocation to Streamline, you should ensure that you send your new proxy card or written notice of revocation in sufficient time for it to be received by Streamline before the Special Meeting.

Please note that if you hold your Streamline common stock in “street name,” and you have instructed a bank, brokerage firm or other nominee to vote your Streamline common stock, the above-described options for revoking your voting instructions do not apply, and instead you should contact your bank, brokerage firm or other nominee for instructions regarding how to change or revoke your vote.

Any adjournment or postponement of the Special Meeting for the purpose of soliciting additional proxies will allow Streamline stockholders who have already sent in their proxies to revoke them at any time prior to their use at the Special Meeting, as adjourned or postponed.

Q:	*What happens if I sell my shares of Streamline common stock before the Special Meeting?*

If you transfer your shares before the Special Meeting, you will retain the right to vote such shares at the Special Meeting, but you will have transferred the right to receive the Merger Consideration to the person to whom you transfer your shares. In order to receive the Merger Consideration, you must hold your shares of Streamline common stock through completion of the Merger.

Q:	*What happens if I sell my shares of Streamline common stock after the Special Meeting but before the Effective Time?*

If you transfer your shares after the Special Meeting but before the Effective Time, you will have transferred the right to receive the Merger Consideration to the person to whom you transfer your shares. In order to receive the Merger Consideration, you must hold your shares of Streamline common stock through completion of the Merger.

Q:	*Should I send in my stock certificates now?*

No. If you hold your Streamline common stock in certificated form, you will receive a letter of transmittal shortly after the Merger is consummated instructing you how to surrender your stock certificates to a paying agent, to be designated by Parent, in order to receive the Merger Consideration to which you are entitled. Please do not send in your stock certificates right now or with your proxy card.

Table of Contents

Q:	*How many shares must be present to constitute a quorum for the meeting?*

Pursuant to the Voting Agreements and subject to the terms and conditions thereof, the supporting stockholders have agreed, among other things, to be represented virtually in person or by proxy at the Special Meeting in order for all shares of Streamline common stock held by the supporting stockholders to be counted as present for purposes of establishing a quorum.

Q:	*What if I abstain from voting or fail to vote or submit a proxy?*

The required vote to approve the Merger Proposal is based on the total number of shares of Streamline common stock issued and outstanding as of the close of business on the Record Date, not just shares of Streamline common stock that are voted at the Special Meeting. Failure to vote virtually or by proxy at the Special Meeting, broker non-votes (if any) and abstentions will have the same effect as a vote “AGAINST” the Merger Proposal. The requisite number of shares to approve the Compensation Proposal and the Adjournment Proposal is based on the total number of shares of Streamline common stock present or represented by proxy at the Special Meeting and entitled to vote on the proposals, assuming a quorum is present. Failure to vote virtually or by proxy at the Special Meeting and broker non-votes (if any) will have no effect on the outcome of the Compensation Proposal or the Adjournment Proposal (assuming, in the case of the Compensation Proposal, a quorum is present). Abstentions with respect to the Compensation Proposal and the Adjournment Proposal will have the same effect as a vote “AGAINST” each proposal.

Q:	*Will my shares be voted if I do not sign and return my proxy card or vote over the internet, by mail, by telephone or by attendance at the Special Meeting?*

If you are a stockholder of record and you do not sign and return your proxy card by mail or vote over the internet, by telephone or by attendance at the Special Meeting, your shares will not be voted at the Special Meeting and will not be counted for purposes of determining whether a quorum exists. If you are a beneficial owner of shares held in “street name” by your bank, brokerage firm or other nominee, you should have received a voting instruction card with these proxy materials from that organization rather than from Streamline. Follow the instructions from your bank, brokerage firm or other nominee to see which of the above choices are available to you to ensure that your vote is counted. To vote at the Special Meeting, you must obtain a “legal proxy” from your bank, brokerage firm or other nominee.

If you fail to submit a proxy or to vote virtually at the Special Meeting or fail to instruct your bank, brokerage firm or other nominee how to vote with respect to the Merger Proposal, it will have the same effect as a vote “AGAINST” the Merger Proposal. If you fail to submit a proxy or to vote virtually at the Special Meeting or fail to instruct your bank, brokerage firm or other nominee how to with respect to the Compensation Proposal or the Adjournment Proposal, it will have no effect on the outcome of such proposal (assuming, in the case of the Compensation Proposal, a quorum is present).

Q:	*What is a broker non-vote?*

A so-called “broker non-vote” results when banks, brokerage firms and other nominees return a valid proxy but do not vote on a particular proposal because they do not have discretionary authority to vote on the matter and have not received specific voting instructions from the beneficial owner of those shares. Broker non-votes count toward a quorum only if at least one proposal is presented with respect to “routine” matters to which the bank, brokerage firm or other nominee has discretionary authority. All proposals described in this proxy statement to be voted on at the Special Meeting are considered “non-routine” matters, and, therefore, broker non-votes, if any, will not be counted as present and entitled to vote for purposes of determining a quorum at the Special Meeting. The effect of not instructing your broker how you wish your shares to be voted will be the same as a vote “AGAINST” the Merger Proposal but will not have an effect on the outcome of the Compensation Proposal or the Adjournment Proposal (assuming, in the case of the Compensation Proposal, a quorum is present).

Q:	*Will my shares held in* “*street name” or another form of record ownership be combined for voting purposes with shares I hold of record?*

No. Because any shares of Streamline commons stock you may hold in “street name” will be deemed to be held by a different stockholder than any shares you hold of record, any shares so held will not be combined for voting purposes with shares you hold of record. Similarly, if you own shares in various registered forms, such as jointly with your spouse, as trustee of a trust or as custodian for a minor, you will receive, and will need to sign and return, a separate proxy card for those shares because they are held in a different form of record ownership. Shares held by a corporation or business entity must be voted by an authorized officer of the entity. Shares held in an individual retirement account must be voted under the rules governing the account.

Table of Contents

Q:	*What does it mean if I receive more than one set of proxy materials?*

You may receive more than one set of voting materials for the Special Meeting, including multiple copies of this proxy statement and multiple proxy cards or voting instruction cards. For example, if you hold your Streamline common stock in more than one brokerage account, you will receive a separate voting instruction card for each brokerage account in which you hold shares. If you are a stockholder of record and your shares are registered in more than one name, you will receive more than one proxy card. Please submit each separate proxy card or voting instruction card that you receive by following the instructions set forth in each separate proxy card or voting instruction card.

Q:	*Who will count the votes?*

A:	The votes will be counted by the inspector of election appointed for the Special Meeting.

Q:	*Can I participate if I am unable to attend the Special Meeting?*

If you are a Streamline stockholder of record and are unable to attend the Special Meeting, you may participate by completing, signing, dating and returning your proxy card or by voting over the internet, by telephone or by mail. If your shares are held in “street name” by your bank, brokerage firm or other nominee, you must direct your bank, brokerage firm or other nominee on how to vote, and you will receive instructions from your bank, brokerage firm or other nominee describing how to vote your shares of Streamline common stock. Please check with your bank, brokerage firm or other nominee and follow the voting procedures your bank, brokerage firm or other nominee provides.

Q:	*Where can I find the voting results of the Special Meeting?*

A:	Streamline intends to announce preliminary voting results at the Special Meeting and publish final results in a Current Report on Form 8-K that will be filed with the SEC following the Special Meeting. All reports that Streamline files with the SEC are publicly available when filed.

Q:	*What happens if the Merger is not completed?*

If the Merger Agreement is not adopted by Streamline stockholders or if the Merger is not completed for any other reason, Streamline stockholders will not receive any Merger Consideration for their shares of Streamline common stock in connection with the Merger. Instead, Streamline will remain an independent public company, Streamline common stock will continue to be listed and traded on Nasdaq and registered under the Exchange Act, and Streamline will continue to file periodic reports with the SEC. Under certain specific circumstances, Streamline is required to pay Parent the Termination Fee. For more information on the Termination Fee and the circumstances in which it is payable, see the section titled “The Merger Agreement—Termination Fee and Expenses” beginning on page 75 of this proxy statement.

Q:	*How can I obtain additional information about Streamline?*

Streamline will provide copies of this proxy statement and its most recent Annual Report to Stockholders, including its Annual Report on Form 10-K, without charge to any stockholder who makes a written request to Streamline’s Corporate Secretary at Streamline Health Solutions, Inc., 2400 Old Milton Pkwy, Box 1353, Alpharetta, GA 30009, Attention: Corporate Secretary. Streamline’s Annual Report on Form 10-K and other SEC filings may also be accessed at www.sec.gov or on the “Investor Relations” section of Streamline’s website at https://streamlinehealth.net/investor-relations. Streamline’s website address is provided as an inactive textual reference only. The information provided on or accessible through our website is not part of this proxy statement and is not incorporated by reference in this proxy statement by this or any other reference to our website provided in this proxy statement.

Q:	*How many copies of this proxy statement and related voting materials should I receive if I share an address with another stockholder?*

The SEC has adopted rules that permit companies and intermediaries, such as brokers, to satisfy the delivery requirements for proxy statements and annual reports with respect to two or more stockholders sharing the same address by delivering a single annual report or proxy statement, as applicable, addressed to those stockholders. This process, which is commonly referred to as “householding,” potentially provides extra convenience for stockholders and cost savings for companies.

Table of Contents

Streamline and some brokers may be householding our proxy materials by delivering proxy materials to multiple stockholders who request a copy and share an address, unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker or us that they or we will be householding materials to your address, householding will continue until you are notified otherwise or until you revoke your consent. If at any time you no longer wish to participate in householding and would prefer to receive a separate proxy statement and annual report, please notify your broker if your shares are held in a brokerage account or Streamline if you are a stockholder of record. You can notify us by sending a written request to Streamline’s Corporate Secretary at Streamline Health Solutions, Inc., 2400 Old Milton Pkwy, Box 1353, Alpharetta, GA 30009, Attention: Corporate Secretary, or calling (888) 997-8732. Stockholders who share a single address, but receive multiple copies of this proxy statement, may request that in the future they receive a single copy by notifying Streamline at the telephone or address set forth in the prior sentence. In addition, Streamline will promptly deliver, upon written or oral request to the address or telephone number above, a separate copy of this proxy statement to a stockholder at a shared address to which a single copy of the documents was delivered pursuant to a prior request.

Q:	*Who can help answer my questions?*

If you have any questions about the Special Meeting, the Merger Agreement, the Merger, the proposals to be voted on at the Special Meeting or this proxy statement, would like additional copies of this proxy statement, need to obtain proxy cards or other information related to this proxy solicitation or need help submitting a proxy or voting your shares of Streamline common stock, you should contact:

Streamline Health Solutions, Inc.

2400 Old Milton Pkwy, P.O. Box 1353

Alpharetta, GA 30009

Attention: Corporate Secretary

(888) 997-8732

Alliance Advisors, LLC

150 Clove Rd #400

Little Falls Township, NJ 07424
1-844-202-7145

Table of Contents

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This proxy statement and other documents incorporated by reference into this proxy statement contain forward-looking statements within the meaning of the federal securities laws. Forward-looking statements include, without limitation, projections, predictions, expectations, or beliefs about future events or results and all other statements that are not statements of historical fact. Such statements may include statements regarding the Closing and the expected timing thereof, the expected value provided to stockholders as a result of the Merger, the management of the Company upon closing of the Merger, the Company’s operating and strategic plans upon closing of the Merger, and expectations or projections regarding the Company’s future financial performance or business outlook. Such forward-looking statements are based on various assumptions as of the time they are made, all of which are subject to change, and are inherently subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are often accompanied by words that convey projected future events or outcomes such as “expect,” “believe,” “estimate,” “plan,” “project,” “anticipate,” “intend,” “will,” “may,” “view,” “opportunity,” “potential,” “aim,” “could,” “would,” “seek,” “might,” “considered,” “continue,” “target” or words of similar meaning or the negatives of these words or other statements concerning opinions or judgments of the Company or its management about future events or outcomes or that otherwise convey uncertainty about future events or outcomes.

By their nature, forward-looking statements address matters that involve risks and uncertainties because they relate to events and depend upon future circumstances that may or may not occur, such as the Closing and the anticipated benefits thereof. There can be no assurance that actual results, performance, or achievements of the Company will not differ materially from any projected future results, performance or achievements expressed or implied by such forward-looking statements or any related oral statements. Actual future results, performance or achievements may differ materially from historical results or those anticipated depending on a variety of factors, some of which are beyond the control of the Company, including, but not limited to: (i) the occurrence of any event, change or other circumstances that could give rise to the termination of the Merger Agreement; (ii) the inability to close the Merger due to the failure to obtain stockholder approval for the Merger or the failure to satisfy other conditions to closing of the Merger; (iii) risks related to disruption of management’s attention from the Company’s ongoing business operations due to the Merger; (iv) unexpected costs, charges or expenses resulting from the Merger; (v) the Company’s ability to retain and hire key personnel; (vi) certain restrictions during the pendency of the Merger that may impact the Company’s ability to pursue certain business opportunities or strategic transactions; (vii) the ability of MDaudit to obtain necessary financing arrangements, if any; (viii) potential litigation relating to the Merger that could be instituted against the parties to the Merger Agreement or their respective directors, managers or officers, including the effects of any outcomes related thereto; (ix) the effect of the announcement of the Merger on the Company’s relationships with its customers, operating results and business generally; (x) continued availability of capital and financing and rating agency actions; (xi) legislative, regulatory and economic developments affecting the Company’s business; (xii) general economic and market developments and conditions; (xiii) unpredictability and severity of catastrophic events, including but not limited to acts of terrorism, pandemics, outbreaks of war or hostilities, as well as the Company’s response to any of the aforementioned factors; (xiv) significant transaction costs associated with the Merger; (xv) the possibility that the Merger may be more expensive to complete than anticipated, including as a result of unexpected factors or events; and (xvi) the risk that the Merger will not be consummated in a timely manner, if at all. Additional risk factors that could cause actual results to differ materially from expectations include, but are not limited to, the risks identified by the Company in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s Form 10-K for the fiscal year ended January 31, 2025, as amended, and comparable sections of the Company’s Quarterly Reports on Form 10-Q and other filings, which have been filed with the SEC and are available on the SEC’s website at www.sec.gov.

While the list of factors presented here and in such filings with the SEC is considered representative, no such list should be considered a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. All of the forward-looking statements made in this proxy statement are expressly qualified by the cautionary statements contained or referred to herein. The actual results or developments anticipated may not be realized or, even if substantially realized, they may not have the expected consequences to or effects on the Company or its business or operations. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material impact on the Company’s financial condition, results of operations, credit rating or liquidity.

Readers are cautioned not to rely on the forward-looking statements contained in this proxy statement and other documents incorporated by reference into this proxy statement. Forward-looking statements speak only as of the date they are made, and the Company does not undertake any obligation to update, revise or clarify these forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

Table of Contents

INFORMATION ABOUT THE COMPANIES

Streamline Health Solutions, Inc.

2400 Old Milton Pkwy

P.O. Box 1353

Alpharetta, Georgia 30009

(888) 997-8732

Streamline is a Delaware corporation that enables healthcare organizations to proactively address revenue leakage and improve financial performance. Streamline delivers integrated solutions, technology-enabled services and analytics that drive compliant revenue leading to improved financial performance across the enterprise. Streamline common stock is listed on Nasdaq under the symbol “STRM.”

Mist Holding Co.

c/o MDaudit

800 Lexington St., Waltham Plaza #1038

Waltham, Massachusetts 02452

(617) 559-0404

Parent is a Delaware corporation. Parent is a holding company that conducts substantially all activities through its wholly owned subsidiary, Hayes Management Consulting LLC, a Massachusetts limited liability company doing business as “MDaudit.” MDaudit is a leading healthcare technology provider that partners with the nation’s premier healthcare systems to reduce compliance risk, improve efficiency, retain revenue, and enhance communication between cross-functional teams. Bringing solutions to an industry in transformation, MDaudit enables organizations to minimize billing risks and maximize revenue with an AI-powered, integrated, cloud-based platform that leverages the power of collaboration between people and sophisticated technology to keep humans at the forefront of decision-making while driving sustainable change.

MD BE Merger Sub, Inc.

c/o MDaudit

800 Lexington St., Waltham Plaza #1038

Waltham, Massachusetts 02452

(617) 559-0404

Merger Sub is a Delaware corporation and a wholly owned subsidiary of Parent. Merger Sub was incorporated by Parent solely in contemplation of the transactions contemplated by the Merger Agreement. Merger Sub has not conducted any business and has no assets, liabilities or obligations of any nature other than as set forth in the Merger Agreement. Upon completion of the Merger, Merger Sub will cease to exist and Streamline will continue as the surviving corporation.

Table of Contents

THE SPECIAL MEETING

General

This proxy statement is first being mailed on or about July 10, 2025 and constitutes notice of the Special Meeting in conformity with the requirements of the DGCL and the Bylaws.

This proxy statement is being provided to Streamline stockholders as part of a solicitation of proxies by the Streamline Board for use at the Special Meeting and at any adjournments or postponements of such Special Meeting. This proxy statement provides Streamline stockholders with important information about the Special Meeting and the proposals to be voted on at the Special Meeting. Streamline stockholders should carefully read this proxy statement, including any documents incorporated by reference into this proxy statement and the annexes to this proxy statement, in its entirety.

Date, Time and Place of the Special Meeting

The Special Meeting will be held virtually on August 7, 2025, at 9:00 a.m. Eastern Time. Streamline stockholders as of the close of business on the Record Date will be entitled to notice of, and to vote at, the Special Meeting by visiting https://meetnow.global/MJHXM7U. You will not be able to attend the Special Meeting physically in person.

Shares of Streamline common stock held directly in your name as a stockholder of record may be voted at the Special Meeting via https://meetnow.global/MJHXM7U, using the 15-digit control number located on your proxy card. If you did not receive a 15-digit control number and wish to vote virtually at the Special Meeting, you should follow the instructions from your bank, brokerage firm or other nominee, including any requirement to obtain a legal proxy.

Pre-Registering for the Special Meeting

In order to attend the Special Meeting, you must register in advance at https://meetnow.global/MJHXM7U and provide the control number located on your proxy card.

Purposes of the Special Meeting

At the Special Meeting, Streamline stockholders will be asked to vote upon the Merger Proposal, the Compensation Proposal and the Adjournment Proposal. If holders of shares of Streamline common stock fail to adopt the Merger Agreement by approving the Merger Proposal, the Merger will not occur. A copy of the Merger Agreement is attached to this proxy statement as Annex A and incorporated herein by reference, and the material provisions of the Merger Agreement are described under “The Merger Agreement” beginning on page 55 of this proxy statement.

In accordance with the Bylaws, Streamline will transact no other business at the Special Meeting.

Recommendation of the Streamline Board

At a special meeting held on May 28, 2025, the Streamline Board unanimously (i) approved and declared advisable the Merger Agreement and the transactions contemplated by the Merger Agreement, including the Merger, (ii) determined that the Merger Agreement and the transactions contemplated by the Merger Agreement, including the Merger, are fair to, and in the best interests of, Streamline and the holders of shares of Streamline common stock, (iii) recommended that holders of shares of Streamline common stock adopt the Merger Agreement at the Special Meeting, and (iv) directed that the Merger Agreement be submitted to the holders of shares of Streamline common stock for adoption at the Special Meeting.

Accordingly, the Streamline Board unanimously recommends that Streamline stockholders vote “FOR” the Merger Proposal, “FOR” the Compensation Proposal and “FOR” the Adjournment Proposal.

Outstanding Shares as of the Record Date

As of the Record Date, there were 4,356,062 shares of Streamline common stock issued and outstanding, held by approximately 2,300 holders of record. Each share of Streamline common stock is entitled to one vote on each matter to be considered at the Special Meeting.

Stockholders may request an appointment to inspect a complete list of stockholders entitled to vote at the Special Meeting for any purpose germane to the Special Meeting at Streamline’s principal executive offices located at 2400 Old Milton Pkwy, Box 1353, Alpharetta, GA 30009, during ordinary business hours within 10 days prior to the Special Meeting.

Table of Contents

Record Date; Stockholders Entitled to Vote

The Record Date for the determination of stockholders entitled to notice of and to vote at the Special Meeting is June 23, 2025. Only holders of Streamline common stock as of the close of business on the Record Date are entitled to receive notice of, and vote at, the Special Meeting or any adjournment or postponement thereof. Streamline’s official stock ownership records will conclusively determine whether a stockholder is a “holder of record” as of the record date.

Quorum and Broker Non-Votes

Holders of a majority of the shares of Streamline common stock issued and outstanding on the Record Date and entitled to vote at the Special Meeting must be a present or represented by proxy at the Special Meeting to constitute a quorum for the transaction of business at the Special Meeting. If you fail to submit a proxy or to vote virtually at the Special Meeting, or fail to instruct your bank, brokerage firm or other nominee how to vote, your shares of Streamline common stock will not be counted towards a quorum. Marks to “ABSTAIN” on any proposal are considered present for purposes of establishing a quorum. In the event that a quorum is not present at the Special Meeting, it is expected that the Special Meeting will be adjourned or postponed. If the Special Meeting is postponed or adjourned, it will not affect the ability of holders of record of Streamline common stock as of the Record Date to exercise their voting rights or to revoke any previously granted proxy using the methods described below; provided, however, if a new record date is set for an adjourned meeting, a new quorum will be required to be established. There must be a quorum for business to be conducted at the Special Meeting.

As noted above, pursuant to the Voting Agreements and subject to the terms and conditions thereof, the supporting stockholders have agreed, among other things, to be represented virtually or by proxy at the Special Meeting in order for all shares of Streamline common stock held by the supporting stockholders to be counted as present for purposes of establishing a quorum.

Banks, brokerage firms and other nominees who hold shares in “street name” for the accounts of their clients may vote such shares either as directed by their clients or in their own discretion on “routine” matters. When a broker does not receive instructions from a beneficial owner on how to vote shares with respect to a “non-routine” matter, a “broker non-vote” occurs. “Broker non-votes” will not be treated as present for purposes of determining whether a quorum is present. All proposals described in this proxy statement to be voted on at the Special Meeting are considered “non-routine” matters.

Your shares will be counted for purposes of determining if there is a quorum, whether representing votes for, against or abstained, if you (1) attend the Special Meeting or (2) have voted via the internet, by telephone or by properly submitting a proxy card or voting instruction card by mail.

Required Vote

The votes required for each proposal are as follows:

Proposal 1—The Merger Proposal: The affirmative vote of at least two-thirds (66 2/3%) of the issued and outstanding shares of Streamline common stock entitled to vote thereon is required to approve the Merger Proposal. If you mark “ABSTAIN” on your proxy, it will have the same effect as a vote “AGAINST” the Merger Proposal. If you fail to submit a proxy or to vote virtually at the Special Meeting or fail to instruct your bank, brokerage firm or other nominee how to vote with respect to the Merger Proposal, it will have the same effect as a vote “AGAINST” the Merger Proposal.

Proposal 2—The Compensation Proposal: The affirmative vote of a majority of the shares of Streamline common stock present or represented by proxy at the Special Meeting and entitled to vote thereon is required to approve (on a non-binding, advisory basis) the Compensation Proposal. If you mark “ABSTAIN” on your proxy, it will have the same effect as a vote “AGAINST” the Compensation Proposal. If you fail to submit a proxy or to vote virtually at the Special Meeting or fail to instruct your bank, brokerage firm or other nominee how to vote with respect to the Compensation Proposal, it will have no effect on the Compensation Proposal (so long as a quorum is present).

Proposal 3—The Adjournment Proposal: The affirmative vote of a majority of the shares of Streamline common stock present or represented by proxy at the Special Meeting and entitled to vote thereon is required to approve the Adjournment Proposal, whether or not a quorum is present. If you mark “ABSTAIN” on your proxy, it will have the same effect as a vote “AGAINST” the Adjournment Proposal. If you fail to submit a proxy or to vote virtually at the Special Meeting or fail to instruct your bank, brokerage firm or other nominee how to with respect to the Adjournment Proposal, it will have no effect on the Adjournment Proposal.

Pursuant to the Voting Agreements and subject to the terms and conditions thereof, the supporting stockholders have agreed, among other things, to vote all shares of Streamline common stock owned by them in favor of the Merger Proposal, the Adjournment Proposal and any other matters necessary for the consummation of the Merger. For more information regarding the Voting Agreements, please see the section of this proxy statement entitled “The Voting Agreements.” For more information regarding the security ownership of the supporting stockholders, please see the section of this proxy statement entitled “Security Ownership of Certain Beneficial Owners and Management.”

Table of Contents

Treatment of Abstentions and Failure to Vote

Abstentions occur when a stockholder marks “ABSTAIN” on their proxy or voting instruction form or attends a meeting but abstains from voting. At the Special Meeting, abstentions will be included in the calculation of the number of shares of Streamline common stock represented at the Special Meeting for purposes of determining whether a quorum has been achieved. Abstentions will have the same effect as a vote “AGAINST” the Merger Proposal, the Compensation Proposal and the Adjournment Proposal.

If you fail to submit a proxy or to vote virtually at the Special Meeting, or fail to instruct your bank, brokerage firm or other nominee how to vote, your shares will not be voted at the Special Meeting and will not be counted for purposes of determining whether a quorum exists. The failure to submit a proxy or to vote virtually at the Special Meeting, or the failure to instruct your bank, brokerage firm or other nominee how to vote, will have the same effect as a vote “AGAINST” the Merger Proposal but will have no effect on the outcome of the Compensation Proposal or Adjournment Proposal (assuming, in the case of the Compensation Proposal, a quorum is present).

Shares and Voting of Streamline’s Directors and Executive Officers

As of the Record Date, Streamline directors, executive officers and their affiliates, as a group, owned and were entitled to vote 950,669 shares of Streamline common stock, or approximately 21.82% of the outstanding shares of Streamline common stock. Streamline currently expects that these directors and executive officers will vote their shares in favor of the Merger Proposal and each of the other proposals described in this proxy statement, although, except as set forth below with respect to the Voting Agreements, none of the directors and executive officers are obligated to do so.

As noted above, pursuant to the Voting Agreements and subject to the terms and conditions thereof, the supporting stockholders have agreed, among other things, to vote all shares of Streamline common stock owned by the supporting stockholders in favor of the Merger Proposal, the Adjournment Proposal and any other matters necessary for the consummation of the Merger. For more information regarding the Voting Agreements, please see the section of this proxy statement entitled “The Voting Agreements.” For more information regarding the security ownership of the supporting stockholders, please see the section of this proxy statement entitled “Security Ownership of Certain Beneficial Owners and Management.”

How to Vote or Have Your Shares Voted

Streamline stockholders of record may vote their shares of Streamline common stock virtually at the Special Meeting or submit a proxy to have their shares of Streamline common stock voted at the Special Meeting in one of the following ways:

●

By Internet. Streamline stockholders of record may vote on the internet at http://www.envisionreports.com/STRM-SPC. Please have your proxy card available when going online and follow the online instructions. Stockholders that vote by internet must bear all costs associated with electronic access, including internet access fees. Internet voting for stockholders of record is available up until 11:59 p.m. Eastern Time on August 6, 2025, the day preceding the Special Meeting. The internet voting procedures are designed to authenticate each stockholder by use of a control number located on each stockholder’s proxy card to allow stockholders to vote their shares and to confirm that their instructions have been properly recorded. The control number can be found on the enclosed proxy card.

●

During the Special Meeting. If you attend the virtual Special Meeting and wish to vote at the Special Meeting, you may vote through https://meetnow.global/MJHXM7U.

Whether or not you plan to participate in the Special Meeting, Streamline urges you to submit your proxy by completing and returning the proxy card as promptly as possible, or by submitting your proxy by telephone or via the internet, prior to the Special Meeting to ensure that your shares of Streamline common stock will be represented and voted at the Special Meeting if you are unable to participate.

Table of Contents

The Streamline Board has appointed certain persons as proxy holders to vote proxies in accordance with the instructions of Streamline stockholders. If you are a stockholder of record and you authorize these proxy holders to vote your shares of Streamline common stock with respect to any matter to be acted upon, your shares will be voted in accordance with your instructions in your proxy. If you are a stockholder of record and you authorize these proxy holders to vote your shares but do not specify how your shares should be voted on a proposal, these proxy holders will vote your shares on such proposals as the Streamline Board recommends. If any other matter properly comes before the Special Meeting, these proxy holders will vote on that matter in their discretion.

If, as of the Record Date, your shares of Streamline common stock are registered directly in your name with Streamline’s transfer agent, Computershare Inc., you are considered the stockholder of record with respect to those shares. As the stockholder of record, you have the right to vote virtually or to grant a proxy for your vote directly to Streamline or to a third party to vote at the Special Meeting.

If, as of the Record Date, your shares were held in an account at a bank, brokerage firm or other nominee, you are the beneficial owner of shares held in “street name,” and, for the purposes of this proxy statement, a beneficial owner, and your bank, brokerage firm or other nominee is considered the stockholder of record with respect to those shares. If you are a beneficial owner, you have a right to direct your bank, brokerage firm or other nominee on how to vote the shares held in your account. The availability of internet or telephonic voting will depend on the nominee’s voting process. Please check with your bank, brokerage firm or other nominee and follow the voting procedures your bank, brokerage firm or other nominee provides.

In accordance with the rules of Nasdaq, your bank, brokerage firm or other nominee may generally vote on “routine” matters when they have not received voting instructions from you. However, such banks, brokerage firms and other nominees are precluded from exercising their voting discretion with respect to “non-routine” matters. If you are a beneficial owner and do not provide these instructions, a “non-vote” occurs with respect to those matters. All proposals described in this proxy statement to be voted on at the Special Meeting are considered “non-routine” matters. Accordingly, if you are a beneficial owner and do not provide your bank, brokerage firm or other nominee instructions on how to vote your shares of Streamline common stock, your bank, brokerage firm or other nominee generally will not be permitted to vote your shares on any of the proposals. The effect of not instructing your broker how you wish your shares to be voted will be the same as a vote “AGAINST” the Merger Proposal but will not have an effect on the Compensation Proposal or the Adjournment Proposal (assuming, in the case of the Compensation Proposal, a quorum is present). If you are a beneficial holder, Streamline strongly encourages you to provide voting instructions to your bank, brokerage firm or other nominee so that your vote will be counted on all matters.

If you are a beneficial owner, you are invited to participate in the Special Meeting; however, you may not vote your shares at the Special Meeting unless you obtain a “legal proxy” from your bank, brokerage firm or other nominee that holds your shares, giving you the right to vote the shares at the Special Meeting.

Revocation of Proxies

Streamline stockholders of record may revoke their proxies at any time prior to the voting at the Special Meeting in any of the following ways:

●

delivering a written notice of revocation of your proxy to our Corporate Secretary at Streamline Health Solutions, Inc., 2400 Old Milton Pkwy, Box 1353, Alpharetta, GA 30009, Attention: Corporate Secretary, prior to the Special Meeting;

●

submitting a new proxy by telephone prior to 11:59 p.m. Eastern Time on August 6, 2025, the date preceding the Special Meeting;

●

submitting a new proxy by internet prior to 11:59 p.m. Eastern Time on August 6, 2025, the date preceding the Special Meeting; or

●

attending and voting virtually at the Special Meeting.

Table of Contents

Shares Held in Name of Broker

If your shares are held by your bank, brokerage firm or other nominee, often referred to as held in “street name,” you will receive a form from your bank, brokerage firm or other nominee seeking instruction as to how your shares should be voted. You should contact your bank, brokerage firm or other nominee with questions about how to provide or revoke your instructions.

Tabulation of Votes

An inspector of election appointed for the Special Meeting will count the votes.

Solicitation of Proxies

The Streamline Board is soliciting your proxy, and Streamline will bear the expense of electronically hosting, printing and mailing proxy materials and soliciting proxies that we are seeking. Solicitation initially will be made by mail. In addition to the solicitation of proxies by mail, solicitation may be made by certain of our directors, officers, employees and agents, including, but not limited to, our proxy solicitor, Alliance Advisors, in person, by telephone, or via electronic or facsimile transmission. Streamline has retained Alliance Advisors to assist in the solicitation of proxies on behalf of the Streamline Board for an estimated fee of $15,000 plus call center costs and reimbursement of reasonable expenses. Our directors, officers and other employees will receive no additional compensation for any such solicitations. We will request brokers and nominees who hold shares of our common stock in their names to furnish proxy materials to beneficial owners of such shares, and we will reimburse such brokers and nominees for the reasonable expenses incurred in forwarding the materials to such beneficial owners. Your cooperation in voting promptly will help to avoid additional expense. IF YOU NEED ASSISTANCE WITH THE VOTING OF YOUR SHARES, YOU MAY CONTACT ALLIANCE ADVISORS TOLL-FREE AT 1-844-202-7145.

Householding of Special Meeting Materials

Adjournments

The Special Meeting may be adjourned by the affirmative vote of a majority of the shares of Streamline common stock present or represented by proxy at the Special Meeting and entitled to vote thereat, whether or not a quorum is present.

Failure of a quorum to be represented at the Special Meeting may result in an adjournment of the Special Meeting and may subject Streamline to additional expense. Even if a quorum is present, the Special Meeting may also be adjourned one or more times in order to provide more time to solicit additional proxies in favor of approval of the Merger Proposal if sufficient votes are cast in favor of the Adjournment Proposal. In addition, the Special Meeting may be postponed by the Streamline Board in its discretion.

Notice need not be given of any adjourned meeting if the time and place thereof are announced at the meeting at which the adjournment is taken. If the adjournment is for more than 30 days, a notice of the adjourned meeting will be given to each stockholder of record entitled to vote at the adjourned meeting. If, after any adjournment, a new record date for the determination of stockholders entitled to vote is fixed for any adjourned meeting, the Streamline Board shall fix a new record date for notice of such adjourned meeting and shall give notice of the adjourned meeting to each stockholder of record entitled to vote at such adjourned meeting as of the record date fixed for notice of such adjourned meeting.

Questions and Additional Information

You may contact Streamline’s proxy solicitor, Alliance Advisors, toll-free at 1-844-202-7145 or by email at STRM@AllianceAdvisors.com, with any questions about the Special Meeting, the Merger Agreement, the Merger, the proposals to be voted on at the Special Meeting or this proxy statement, if you would like additional copies of this proxy statement, if you need to obtain proxy cards or other information related to the proxy solicitation or if you need help submitting a proxy or voting your shares of Streamline common stock.

Table of Contents

THE MERGER

This section describes the material aspects of the Merger. This section may not contain all of the information that is important to you. You should carefully read this entire proxy statement and the documents incorporated by reference into this proxy statement, including the full text of the Merger Agreement, a copy of which is attached to this proxy statement as Annex A, for a more complete understanding of the Merger. In addition, important information about Streamline is included in or incorporated by reference into this proxy statement. See the section titled “Where You Can Find More Information.”

Effects of the Merger

If the Merger Agreement is adopted by the Streamline stockholders and the other conditions to the Closing are either satisfied or waived, Merger Sub will be merged with and into Streamline, with Streamline continuing as the surviving corporation and a wholly owned subsidiary of Parent.

As a result of the Merger, each share of Streamline common stock issued and outstanding as of immediately prior to the Effective Time (other than any dissenting shares or other excluded shares) will automatically be cancelled and converted into the right to receive the Merger Consideration of $5.34 per share in cash, without interest.

Shares of Streamline common stock are listed and trade on Nasdaq under the symbol “STRM.” As a result of the Merger, Streamline will cease to be a publicly traded company and will become a wholly owned subsidiary of Parent. Prior to the Effective Time, we will cooperate with Parent to delist the shares of Streamline common stock from Nasdaq and deregister the shares of Streamline common stock under the Exchange Act, provided that such delisting and deregistration will not be effective until after the Effective Time. Upon such delisting and deregistration, we will no longer be a publicly traded company and will no longer be required to file periodic reports with the SEC, in each case in accordance with applicable law, rules and regulations. If the Merger is consummated, you will not own any shares of the capital stock of the surviving corporation or Parent.

Expected Timing of the Merger

Effect on Streamline if the Merger is Not Completed

If the Merger Agreement is not adopted by the affirmative vote of at least two-thirds (66 2/3%) of the issued and outstanding shares of Streamline common stock entitled to vote thereon or if the Merger is not completed for any other reason, Streamline stockholders will not receive any Merger Consideration or other payment for their shares (or interests in shares) of Streamline common stock in connection with the Merger. Instead, Streamline will remain an independent public company, Streamline common stock will continue to be listed and traded on Nasdaq and registered under the Exchange Act, and we will continue to file periodic reports with the SEC.

Furthermore, if the Merger is not completed, and depending on the circumstances that would have caused the Merger not to be completed, it is likely that the price of Streamline common stock will decline significantly. If that were to occur, it is uncertain when, if ever, the price of Streamline common stock would return to the price at which it trades as of the date of this proxy statement.

Accordingly, if the Merger is not completed, there can be no assurance as to the effect of these risks and opportunities on the future value of your shares of Streamline common stock. If the Merger Agreement is not adopted by Streamline stockholders or if the Merger is not completed for any other reason, there can be no assurance that any other transaction acceptable to Streamline will be offered or that Streamline’s business, prospects, financial condition, earnings or results of operation will not be adversely impacted. Further, due to Streamline’s inability to consistently generate sufficient revenues, EBITDA and liquidity to maintain compliance with the financial covenants under the Loan Agreement, continuing as a stand-alone independent company may require that Streamline raise additional financing, which may not be available, or may be dilutive to Streamline stockholders.

Pursuant to the Merger Agreement, under certain circumstances Streamline is permitted to terminate the Merger Agreement in order to enter into a definitive agreement with respect to a superior proposal. For further detail regarding Streamline’s right to terminate the Merger Agreement, please see the section of this proxy statement titled “The Merger Agreement—Termination of the Merger Agreement” beginning on page 74 of this proxy statement.

Table of Contents

In addition, the Merger Agreement provides that, upon termination of the Merger Agreement under certain circumstances, Streamline will be required to pay Parent the Termination Fee, as described under the section titled “The Merger Agreement—Termination Fee and Expenses” beginning on page 75 of this proxy statement.

Merger Consideration

At the Effective Time, by virtue of the Merger and without any action of the holder, each share of Streamline common stock issued and outstanding immediately prior to the Effective Time (other than any dissenting shares or other excluded shares) will automatically be cancelled and converted into the right to receive $5.34 per share of Streamline common stock in cash, without interest.

Any shares of Streamline common stock held by holders who have not voted in favor of the adoption of the Merger Agreement (or consented thereto in writing) and who are entitled to demand, and who have perfected a demand, for appraisal rights of such shares in accordance with Section 262 of the DGCL are considered “dissenting shares” and will not be converted into the right to receive the Merger Consideration, but instead will be entitled to only such rights as are granted by Section 262 of the DGCL. Any shares of Streamline common stock held by the Company as treasury stock and not held on behalf of third parties, and any shares of Streamline common stock owned by Parent, Merger Sub or any direct or indirect wholly owned subsidiary of Parent or Merger Sub (which, together with any dissenting shares, are considered “excluded shares”) will be cancelled for no consideration.

Source: View Original Filing on SEC EDGAR

FAQ

What is the cash price offered to STRM shareholders in the merger?

Each share of STRM will receive $5.34 in cash, without interest, upon closing.

How big is the premium over Streamline Health’s pre-announcement share price?

The offer represents a 138% premium to the 28 May 2025 close and 117% over the 30-day VWAP.

When is the shareholder vote for STRM’s merger with MDaudit?

The virtual Special Meeting is scheduled for 9:00 a.m. ET on 7 August 2025.

What vote is needed to approve the merger proposal?

At least 66 ⅔ % of all outstanding STRM shares must vote FOR; non-votes count as AGAINST.

Are appraisal rights available to dissenting STRM shareholders?

Yes. Holders who strictly follow DGCL §262 can seek a court-determined “fair value” instead of the $5.34 cash.

Is the deal subject to financing or regulatory approvals?

The buyer has sufficient cash on hand; no financing condition exists, and only customary legal clearances are required.

Selected Public Companies	LTM Revenue Multiple	CY 2025E Revenue Multiple
CareCloud, Inc.	1.3x	1.3x
Health Catalyst, Inc.	1.1x	1.1x
HealthStream Inc	2.6x	2.5x
Premier, Inc.	1.9x	2.5x
Spok Holdings, Inc	2.4x	2.3x
TruBridge, Inc.	1.6x	1.6x

Announcement Date	Target	Acquiring Company	LTM Revenue Multiple
05/06/2025	i3 Verticals Healthcare RCM Business	Infinx Inc	2.5x
06/21/2024	Sharecare, Inc.	Altaris, LLC	1.2x
08/07/2024	Xtend Inc	CorroHealth Inc	3.0x
12/06/2023	Acclara	R1 RCM Inc.	2.3x
09/06/2023	NextGen Healthcare, Inc.	Thoma Bravo	2.6x
06/21/2022	Convey Health Solutions Holdings, Inc.	TPG Inc.	3.1x
03/02/2022	Allscripts Hospitals & Physician Segment	N. Harris Computer Corp	0.8x
03/01/2022	Healthcare Resource Group Inc	TruBridge, Inc.	1.3x
08/16/2021	Avelead Consulting LLC	Streamline Health Solutions Inc.	3.4x
11/23/2020	eMDs, Inc.	CompuGroup Medical SE & Co. KGaA	2.5x
02/26/2018	Intermedix Holdings Inc.	R1 RCM Inc.	2.4x

Period	2025E	2026E	2027E	2028E	2029E	2030E	2031E	2032E	2033E	2034E
Total Revenue	$18,384	$20,039	$22,619	$25,914	$29,247	$31,873	$33,342	$34,263	$35,269	$36,305
Gross Profit	$7,284	$8,443	$10,429	$12,849	$16,679	$18,703	$20,524	$21,636	$22,407	$23,199
Adjusted EBITDA⁽¹⁾	($513)	$539	$2,204	$4,293	$6,626	$7,665	$7,987	$8,118	$8,674	$9,250
EBIT⁽²⁾	($7,594)	($6,521)	($4,927)	($3,105)	$721	$1,784	$3,247	$4,139	$4,801	$5,483
Unlevered Free Cash Flow⁽³⁾	($1,393)	($1,130)	$163	$2,320	$4,416	$6,107	$7,228	$7,844	$8,357	$8,909

Period	2024E	2025E	2026E	2027E	2028E
Total Revenue	$17,847	$18,672	$22,202	$27,047	$33,375
Gross Profit	$11,130	$11,064	$13,573	$17,164	$21,833
Adjusted EBITDA⁽¹⁾	$942	$1,059	$2,545	$5,945	$10,393

Name		Position
Wyche T. Green, III		Executive Chairman
Benjamin L. Stilwill		President and Chief Executive Officer
Bryant J. Reeves, III		Chief Financial Officer
Wendy L. Lovvorn		Chief People Officer

[DEFM14A] Streamline Health Solutions, Inc. Merger Proxy Statement

Insights

FAQ

What is the cash price offered to STRM shareholders in the merger?

How big is the premium over Streamline Health’s pre-announcement share price?

When is the shareholder vote for STRM’s merger with MDaudit?

What vote is needed to approve the merger proposal?

Are appraisal rights available to dissenting STRM shareholders?

Is the deal subject to financing or regulatory approvals?

NASDAQ:STRM

STRM Rankings

STRM Latest News

STRM Latest SEC Filings

STRM Stock Data

	Company Restricted Shares
Name	Number of Shares (#)	Value ($)
Executive Officers
Wyche T. “Tee” Green, III	35,666	$190,456
Benjamin L. Stilwill	13,712	$73,222
Bryant J. Reeves, III	9,612	$51,328
Wendy L. Lovvorn	11,686	$62,403

Non-Employee Directors
Matthew Etheridge	⸺	$⸺
Justin J. Ferayorni	16,666	$88,996
Kenan H. Lucas	16,666	$88,996
Jonathan R. Phillips	16,666	$88,996
Judith E. Starkey	16,666	$88,996

	Company Warrants
Name	Number of Shares (#)	Exercise Price ($)	Value ($)
Executive Officers
Wyche T. “Tee” Green, III	59,829	$5.85	$⸺
Benjamin L. Stilwill	⸺	$⸺	$⸺
Bryant J. Reeves, III	⸺	$⸺	$⸺
Wendy L. Lovvorn	⸺	$⸺	$⸺

Non-Employee Directors
Matthew Etheridge	61,403	$5.70	$⸺
Justin J. Ferayorni	29,914	$5.85	$⸺
Kenan H. Lucas	⸺	$⸺	$⸺
Jonathan R. Phillips	2,991	$5.85	$⸺
Judith E. Starkey	⸺	$⸺	$⸺


	o	For Mr. Green and Ms. Lovvorn, up to twelve (12) months or six (6) months, respectively, of partially subsidized COBRA premiums for continued coverage under the Company’s group medical and dental insurance plans (if enrolled) for the executive officer and the executive officer’s eligible dependents;

	●	The effective date of the Merger (and an involuntary termination of employment of the named executive officer, as applicable) occurred on June 23, 2025;
	●	The value per share of Streamline common stock upon consummation of the Merger is $5.34;
	●	Each named executive officer experiences a CIC Qualifying Termination during the Change in Control Period, without taking into account any possible reduction that might be required to avoid the excise tax in connection with Section 280G and Section 4999 of the Code; and
	●	Each named executive officer has complied with all requirements necessary to receive all payments and benefits.

Name	Cash ($)⁽¹⁾⁽²⁾		Equity ($)⁽³⁾		Perquisites/ Benefits ($)		Other⁽⁴⁾		Total ($)
Wyche T. Green, III	$	480,000	$	172,982		─	─		$	652,982
Benjamin L. Stilwill	$	190,130	$	73,359	─		$	75,000	$	338,489
Bryant J. Reeves, III	$	141,940	$	50,820	─		$	45,000	$	237,760

Name	Base Salary Severance ($)		Pro-Rata Bonus ($)		COBRA-Related Benefit		Total ($)
Wyche T. Green, III	$	480,000	─		─		$	480,000
Benjamin L. Stilwill	$	187,500	─		$	2,630	$	190,130
Bryant J. Reeves, III	$	112,500	$	28,125	$	1,315	$	141,940

Name of Beneficial Owner	Streamline Common Stock Beneficially Owned		Percent of Streamline Common Stock Owned
Five Percent Stockholders
Beryl Capital Management LLC⁽¹⁾		374,030		8.59	%
Harbert Discovery Fund, LP⁽²⁾		338,280		7.77	%
GCI Partners Opportunity Fund, LP⁽³⁾		261,138		5.99	%

Directors and Named Executive Officers
Kenan H. Lucas⁽²⁾		338,280		7.77	%
Wyche T. “Tee” Green, III⁽⁴⁾		216,119		4.89	%
Justin J. Ferayorni⁽⁵⁾		200,624		4.57	%
Jonathan R. Phillips⁽⁶⁾		104,102		2.39	%
Matthew Etheridge⁽⁷⁾		92,279		2.09	%
Judith E. Starkey⁽⁸⁾		75,820		1.74	%
Benjamin L. Stilwill⁽⁹⁾		37,518		*
Bryant J. Reeves, III⁽¹⁰⁾		13,514		*
All current directors and executive officers as a group (9 persons)⁽¹¹⁾		1,105,472		24.51	%

	(1)	Based on the Schedule 13G filed with the SEC on June 5, 2025, Beryl Capital Management LLC (“Beryl”) is deemed to have shared voting and dispositive power over 374,030 shares of Streamline common stock held by Beryl Capital Partners II LP (“Beryl Partnership”) or other accounts for which it serves as the investment advisor. As further described below, each of Beryl, Beryl Partnership, Beryl Capital Management LP (“Beryl GP”) and David A Witkin exercises shared voting and dispositive power over 301,389 shares of such 374,030 shares of Streamline common stock, and by virtue of such status, may be deemed to be the beneficial owner of such shares. Additionally, each of Beryl, Beryl GP and Mr. Witkin exercises shared voting and dispositive power over 72,641 shares of such 374,030 shares of Streamline common stock, and by virtue of such status, may be deemed to be the beneficial owner of such shares. Beryl is the investment adviser to Beryl Partnership and other accounts. Beryl is the general partner of Beryl GP, which is the general partner of Beryl Partnership and other private investment funds. Mr. Witkin is the control person of Beryl. The address for Beryl, Beryl GP, Beryl Partnership and Mr. Witkin is 225 Avenue I, Suite 205, Redondo Beach, CA 90277.
	(2)	Based on the Schedule 13D/A filed with the SEC on June 2, 2025, Harbert Discovery Fund, LP (the “Fund”) is deemed to have shared voting and dispositive power over 338,280 shares of Streamline common stock which it purchases, holds and sells for investment purposes. As further described below, each of Harbert Discovery Fund GP, LLC (the “Fund GP”), Harbert Fund Advisors, Inc. (“HFA”), Harbert Management Corporation (“HMC”), Jack Bryant, Kenan Lucas and Raymond Harbert exercises shared voting and dispositive power over 338,280 shares of Streamline common stock purchased by the Fund, and by virtue of such status, may be deemed to be the beneficial owner of such shares. Jack Bryant is Executive Vice President and Senior Managing Director of HMC. Kenan Lucas is the Managing Director and Portfolio Manager of the Fund GP, which serves as general partner of the Fund. Raymond Harbert is the Chairman and Chief Executive Officer of HMC, an alternative asset management firm. Mr. Harbert also serves as the Chairman and Chief Executive Officer of HFA, a wholly owned subsidiary of HMC. The address of the Fund, the Fund GP, HFA, HMC, Mr. Bryant, Mr. Lucas, and Mr. Harbert is 2100 Third Avenue North, Suite 600, Birmingham, AL 35203.
	(3)	Based on Streamline’s Form 10-K for the fiscal year ended January 31, 2025, GCI Partners Opportunity Fund L.P. (the “GCI Partners”) is deemed to have shared voting and dispositive power over 261,138 shares of Streamline common stock which it purchases, holds and sells for investment purposes. Niraj A. Gupta exercises shared voting and dispositive power over the funds for the purchase of the shares of Streamline common stock purchased by GCI Partners, and by virtue of such status, may be deemed to be the beneficial owner of such shares. The address of each of GCI Partners and Niraj A. Gupta is 1350 Avenue of the Americas, 3rd Floor, New York, NY 10019.

	(4)	Includes (i) 35,666 Company Restricted Shares over which the holder has sole voting but no investment power and (ii) 59,829 shares of Streamline common stock issuable pursuant to exercisable Company Warrants held by 121G, LLC of which Mr. Green is the managing member and, as a result, has sole voting and dispositive power with respect to such shares.
	(5)	Based on the Schedule 13D filed with the SEC on November 22, 2024. Tamarack Advisers, LP (“Tamarack Advisers”) is deemed to have sole voting and dispositive power over 92,294 shares of Streamline common stock. Justin J. Ferayorni is deemed to be the beneficial owner of such shares because he is the managing member of the general partner of Tamarack Advisers. The address of Tamarack Advisers and Mr. Ferayorni is 300 Carlsbad Village Drive, Suite 108A-228, Carlsbad, CA 92008. In addition, Mr. Ferayorni also directly, or through family members, beneficially owns 78,416 shares of Streamline common stock, which includes 16,666 Company Restricted Shares over which the holder has sole voting but no investment power. Mr. Ferayorni’s beneficial ownership also includes 29,914 shares issuable pursuant to exercisable Company Warrants held by The Ferayorni Family Trust. Justin J. Ferayorni may be deemed to be the beneficial owner of shares held by The Ferayorni Family Trust because he is a co-trustee of The Ferayorni Family Trust.
	(6)	Includes (i) 16,666 shares of restricted stock over which the holder has sole voting but no investment power, and (ii) 4,833 shares of Streamline common stock held by Mr. Phillip's wife or in her trust. Includes 2,991 shares of Streamline common stock issuable pursuant to exercisable Company Warrants.
	(7)	Includes 61,403 shares of common stock issuable pursuant to exercisable Company Warrants.
	(8)	Includes 16,666 Company Restricted Shares over which the holder has sole voting but no investment power.
	(9)	Includes (i) 13,712 Company Restricted Shares over which the holder has sole voting but no investment power, and (ii) 3 shares of Streamline common stock held by Mr. Stilwill’s wife.
	(10)	Includes 9,612 Company Restricted Shares over which the holder has sole voting but no investment power.
	(11)	Includes (i) Company Options that are currently exercisable or exercisable within 60 days of June 19, 2025, to purchase 666 shares of Streamline common stock, (ii) 154,137 shares of Streamline common stock issuable pursuant to Company Warrants currently exercisable or exercisable within 60 days of June 19, 2025, and (iii) 74,681 shares of Streamline common stock held indirectly.

	Page

ARTICLE I THE MERGER; CLOSING; EFFECTIVE TIME	2
1.1. The Merger	2
1.2. Closing	2
1.3. Effective Time	2

ARTICLE II ORGANIZATIONAL DOCUMENTS OF THE SURVIVING CORPORATION	2
2.1. Certificate of Incorporation of the Surviving Corporation	2
2.2. Bylaws of the Surviving Corporation	2

ARTICLE III DIRECTORS AND OFFICERS OF THE SURVIVING CORPORATION	3
3.1. Directors of the Surviving Corporation	3
3.2. Officers of the Surviving Corporation	3

ARTICLE IV EFFECT OF THE MERGER; EXCHANGE OF SHARES	3
4.1. Effect of the Merger; Conversion of Securities	3
4.2. Exchange of Shares	4
4.3. Treatment of Company Equity Awards and Company Warrants	6
4.4. Adjustments to Prevent Dilution	8

ARTICLE V REPRESENTATIONS AND WARRANTIES	8
5.1. Representations and Warranties of the Company	8
5.2. Representations and Warranties of Parent and Merger Sub	31

ARTICLE VI COVENANTS	34
6.1. Interim Operations	34
6.2. Acquisition Proposals; Change of Recommendation	37
6.3. Proxy Statement Filing; Information Supplied	41
6.4. Company Stockholders Meeting	42
6.5. Efforts; Cooperation; Antitrust Matters	43
6.6. Information; Access and Reports	44
6.7. Stock Exchange Delisting	45
6.8. Publicity	45
6.9. Employee Benefits	46
6.10. Expenses	48
6.11. Indemnification; Insurance	48
6.12. Stockholder Litigation	50
6.13. Cooperation with Financing	50
6.14. Other Actions by the Company	52
6.15. Obligations of Parent	53
6.16. Notification of Certain Matters	53
6.17. Repayment of Indebtedness	53
6.18. FIRPTA Certificates	53
6.19. Resignations	53

ARTICLE VII CONDITIONS	54
7.1. Conditions to Each Party’s Obligation to Effect the Merger	54
7.2. Conditions to Obligations of Parent and Merger Sub	55
7.3. Conditions to Obligation of the Company	56

ARTICLE VIII TERMINATION	56
8.1. Termination	56
8.2. Effect of Termination and Abandonment	57

ARTICLE IX MISCELLANEOUS AND GENERAL	59
9.1. Survival	59
9.2. Modification or Amendment	59
9.3. Waiver	60
9.4. Counterparts	60
9.5. Governing Law and Venue; Waiver of Jury Trial; Specific Performance	60
9.6. Notices	62
9.7. Entire Agreement	63
9.8. No Third-Party Beneficiaries	63
9.9. Obligations of Parent and of the Company	63
9.10. Transfer Taxes	63
9.11. Definitions	64
9.12. Severability	64
9.13. Interpretation; Construction	64
9.14. Successors and Assigns	65
9.15. No Recourse	65
9.16. Necessary Further Actions	65

Term	Section
401(k) Plan	6.9(d)
Action	5.1(h)
Agreement	Preamble
Alternative Acquisition Agreement	6.2(d)(iv)
Antitrust Law	6.5(d)
Bankruptcy and Equity Exception	5.1(c)(i)
Benefit Plans	5.1(i)(i)
Book-Entry Certificates	4.1(a)
Bylaws	2.2
Cain Brothers	5.1(u)
Certificates	4.1(a)
Certificate of Merger	1.3
Change of Recommendation	6.2(d)(iv)
Charter	2.1
Chosen Courts	9.5(a)
Closing	1.2
Closing Date	1.2
Code	4.2(g)
Commission Arrangement	6.9(c)
Company	Preamble
Company Board	Recitals
Company Debt	6.17(a)
Company Disclosure Schedule	5.1
Company Equity Awards	5.1(b)(ii)
Company Option	4.3(a)
Company Permits	5.1(j)(ii)
Company Recommendation	5.1(c)(ii)
Company Reports	5.1(e)(i)
Company Restricted Share	4.3(b)
Company Securities	6.1(b)(iii)
Company Stockholders Meeting	6.4
Company Termination Fee	8.2(b)
Company Warrants	4.3(c)
Confidential Information	5.1(q)(i)
Confidentiality Agreement	6.6(a)
Continuing Employee	6.9(a)
Contract	5.1(d)(ii)
D&O Insurance	6.11(c)
Debt Payoff Amount	6.17(a)
DGCL	Recitals
Dissenting Shares	4.1
DOJ	6.5(b)
DPA	5.1(j)(v)
DTC	4.2(c)(i)
Effective Time	1.3
Enforcement Costs	8.2(c)
ERISA	5.1(i)(i)
Exchange Act	5.1(d)(i)
Excluded Shares	4.1
Existing Stockholders	Recitals
Financing	6.13
FTC	6.5(b)
Governmental Authority	5.1(d)(i)
Indemnified Party or Indemnified Parties	6.11(a)
Insurance Policies	5.1(r)
Intervening Event	6.2(e)(ii)
IRS	5.1(i)(i)
Labor Agreement	5.1(p)(i)
Laws	5.1(j)(i)
Match Period	6.2(e)(i)
Material Contract	5.1(k)(ii)
Maximum Premium	6.11(c)
Merger	Recitals
Merger Consideration	4.1
Merger Sub	Preamble
Multiemployer Plan	5.1(i)(ii)
New York Courts	9.5(a)
Open Source Software	5.1(q)(v)
Order	7.1(b)
Outside Date	8.1(b)
Parent	Preamble
Parent 401(k) Plan	6.9(d)
Parent Disclosure Schedule	5.2
Parties or Party	Preamble
Paying Agent	4.2(a)
Paying Agent Agreement	4.2(a)
Payment Fund	4.2(b)
Preferred Stock	Annex A
Proxy Statement	6.3(a)
Reimbursement Obligations	6.13(b)
SEC	5.1
SEC Clearance Date	6.3(b)
Securities Act	5.1(d)(i)
Security Reviews	5.1(r)(iii)
Service Provider	5.1(i)(i)
Support Agreement	Recitals
Surviving Corporation	1.1
Tail Period	6.11(c)
Takeover Law	5.1(m)
Termination Date	6.9(d)
Third Party IP	5.1(q)(ii)
Trade Controls	5.1(j)(iii)
Transfer Taxes	9.10
WARN Act	5.1(p)(iv)

Stockholder	Shares of Common Stock	Company Options	Company Restricted Shares	Company Warrants
[______]	[●]	[●]	[●]	[●]
[______]	[●]	[●]	[●]	[●]
[______]	[●]	[●]	[●]	[●]

Trending News

[DEFM14A] Streamline Health Solutions, Inc. Merger Proxy Statement

Insights

M&A Specialist positive

Portfolio Manager positive

FAQ

What is the cash price offered to STRM shareholders in the merger?

How big is the premium over Streamline Health’s pre-announcement share price?

When is the shareholder vote for STRM’s merger with MDaudit?

What vote is needed to approve the merger proposal?

Are appraisal rights available to dissenting STRM shareholders?

Is the deal subject to financing or regulatory approvals?

NASDAQ:STRM

STRM Rankings

STRM Latest News

STRM Latest SEC Filings

STRM Stock Data